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CHAPTER 2-1
MEDICAL USES: MEDICAL CONDITIONS

Figure 1. Bryophytes and other herbs on sale in a Yunnan, China, market. The newspaper has the contents of a prescription that is
under preparation, including Rhodobryum. Photo courtesy of Eric Harris.

New Medical Sources
One of the reasons for exploring biological compounds
in bryophytes is the potential for medical use. It's a scary
thought, but substances we know as pesticides and
fungicides that discourage insect feeding and bacterial or
fungal attack are likely to have antibiotic properties that
could prove useful in treating human disease. We know
bryophytes contain numerous potentially useful
compounds, including oligosaccharides, polysaccharides,
sugar alcohols, amino acids, fatty acids, aliphatic
compounds, phenylquinones, and aromatic and phenolic
substances, but much work remains to link medical effects
with specific bryophyte species or compounds (Pant &
Tewari 1990). For this reason, traditional uses named here
should be viewed with caution because we don't know the
dosage needed, side effects, or other precautions that need

to be taken. We do know that traditional medicines that
may be safe for one race of people may not be for others.
After all, those alive today are descendents of survivors.
And diet may affect the ways that some of these
compounds work, causing geographic differences.
Hansen (1994) suggested that fatty acids produced by
members of Hypnaceae (Figure 70) and Brachytheciaceae
(Figure 2) produce high levels of arachidonic acid and EPA
and might be used for "producing unique and highly priced
compounds for pharmaceutical industry." Mosses contain
both n-3 (EPA, 18:3) and n-6 (arachidonic acid, DHGLA,
18:2) fatty acids. Gellerman et al. found that Mnium
(Figure 3), Polytrichum (Figure 4), and Marchantia
(Figure 5) have highly unsaturated lipids. Thus, the
potential is real – we need to explore it.
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Figure 2.
Eurhynchium striatum, a member of the
Brachytheciaceae with a high content of arachidonic acid. Photo
by Michael Lüth, with permission.
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Figure 5. Marchantia polymorpha thallus illustrating the
surface that the Chinese considered to resemble the cross section
of the liver. Photo by Michael Lüth, with permission.

Bryophytes can be cultured to produce medical
compounds. Using knockout genes, we cannot only
sequence the genome of bryophytes, but also determine the
function of individual genes. It is also easier to transplant
genes into the bryophyte genome than into tracheophytes.
This is possible because the bryophyte spends an extended
period of time as a leafy plant with only one set of
chromosomes. The model system Physcomitrella patens
(Figure 6, Figure 7) is superior to the traditional
mammalian production hosts and cultures can even be
stored frozen for ten years, then begin producing again
when thawed and cultured (Beike et al. 2010).
Figure 3. Mnium stellare. The genus Mnium is known to
have highly unsaturated lipids. Photo by Michael Lüth, with
permission.

Figure 4. Polytrichum commune is used in China to reduce
inflammation and fever, as well as to treat the common cold and
kidney and gallstones. Photo by Michael Lüth, with permission.

Asakawa has spent his career studying the secondary
compounds of liverworts. In this time he has found that
some of them produce a number of terpenoids, aromatic
compounds, and acetogenins, several of which show
interesting biological activity (Asakawa 2008; Asakawa et
al. 2013). Among these are agents that cause allergenic
contact dermatitis, insecticides, insect antifeedants,
cytotoxins, piscicides, muscle relaxants, plant growth
regulators, anti-HIV agents, DNA polymerase β inhibitory
compounds, anti-obesity compounds, neurotrophic agents,
NO production inhibitors, antimicrobial agents, and
antifungal agents. However, few of these have reached
application by the medical practitioners.

Figure 6. Physcomitrella patens growing in the wild. Photo
by Michael Lüth, with permission.

Figure 7. Physcomitrella patens growing on agar plates.
Photo by Sabisteb, through Creative Commons.
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Herbal Medicines
Not surprisingly, herbal medicines of China (Figure 1),
India, and Native Americans include bryophytes (Harris
2008). In China, 63 species are known to have medicinal
uses. In India, 22 species are known to have medicinal use,
but only in the Himalayas. Ayurvedic (holistic medicine of
India, over 3000 years old) texts report little or no use.
Native Americans have used bryophytes for drugs, fibers,
and clothing (University of Michigan, Dearborn, 2003).
The mosses Calymperes (Figure 8), Campylopus (Figure
9), and Sphagnum (Figure 10) have been used for
medicinal purposes in Malaysia (Burkill 1966; Tan 2003).
Timmiella (Figure 11) has been used medicinally in Egypt
(Harris 2008).

Figure 10. Sphagnum centrale, considered a medicinal
plant in Malaysia. Photo courtesy of Betsy St. Pierre.

Figure 8. Calymperes erosum, considered a medicinal plant
in Malaysia. Photo by Li Zhang, with permission.

Figure 11. Timmiella barbuloides with capsules. A species
of Timmiella is used for medicine in Egypt. Photo by Michael
Lüth, with permission.

Figure 9. Campylopus introflexus, considered a medicinal
plant in Malaysia. Photo by Michael Lüth, with permission.

Native Americans have long traditions of using
bryophytes for medical purposes. The languages of the
natives of the central coast of British Columbia include
words for Plagiomnium insigne (Figure 12) that mean tiny,
tiny little trees in Oweekeno; this moss is important to them
for medicinal use (Turner 1973; Compton 1993; Harris
2008). The users recognize two different forms of the
species (Compton 1993; Harris 2008). Those that grow
under Douglas fir (Pseudotsuga menziesii; Figure 13) are
less effective medically than those that grow under spruce
(Picea; Figure 14).

Figure 12. Plagiomnium insigne with capsules, a species
used by natives in British Columbia, Canada. Photo from Botany
Website, UBC, with permission.
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Figure 13. Pseudotsuga menziesii forest in snow, habitat for
Plagiomnium insigne. Photo by Dave Powell, USDA, through
Creative Commons.
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Figure 15. Sematophyllum adnatum, a moss used to make a
medicinal tea in the Yucatan of Mexico. Photo by Bob Klips,
with permission.

The moss Rhodobryum (Figure 1) is used to make a
medicinal tea (Franquemont et al. 1990; Harris 2008), and
as you will see below, it has tested medicinal properties
useful for several medical conditions.
Polytrichum
commune (Figure 4) has been boiled to make a tea for
treating colds (Gulabani 1974; Beike et al. 2010).

Figure 14. Picea sitchensis forest floor. Plagiomnium
insigne produces more potent medicine in western spruce forests
compared to those of Douglas fir. Photo by Henry Hartley,
through Creative Commons.

The Doctrine of Signatures (based on the concept that
God provided visual cues through the characteristics of the
plants), highly developed during the European
Renaissance, has dictated the use of a variety of
bryophytes, especially liverworts, in herbal medicine. For
example, liverworts resemble the liver, so they have been
used to treat liver ailments.
Asakawa (2015) names Bryum argenteum (Figure 47)
as an antibacterial moss.
Not only do a number of bryophytes serve as
medicinal herbs, but Sphagnum (Figure 10) has been used
to deliver the medicine by using it to make a suppository
(Stevenson 2012).

Liver Ailments
The most widely known use of bryophytes determined
by its appearance is that of Marchantia polymorpha
(Figure 5) to treat liver and other ailments; the surface
suggests the cross section of liver (Miller & Miller 1979).
In China, it is still used to treat the jaundice of hepatitis and
as an external cure to reduce inflammation (Hu 1987) and
has gained the reputation of cooling and cleansing the liver
(Bland 1971). But it has also been used for liver problems
in Europe (Thieret 1956) and South America (Garcia
Barriga 1992; Roig y Mesa 1945).
Based on the Doctrine of Signatures, it is not
surprising that Marchantia polymorpha (Figure 5) is not
the only species in that genus to be used to treat liver
ailments. In India, M. convoluta is also used (Rao 2009;
Chandra et al. 2017). And Marchantia palacea (Figure
16) is used to treat hepatitis (Sabovljević et al. 2011;
Chandra et al. 2017).

Medicinal Teas
Johannes Enroth (Bryonet 28 January 2009) visited the
Yucatan, Mexico, and discovered mosses in use there. The
local guide was a "coba-maya" who was familiar with uses
of plants. He reported a medical tea made from a moss
growing on tree trunks. Enroth collected a bit and
identified the moss as Sematophyllum adnatum (Figure
15).

Figure 16. Marchantia paleacea, a liverwort used to treat
hepatitis in India. Photo by Jan-Peter Frahm, with permission.
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Perhaps there is more wisdom in these ancient
remedies than at first appears. Asakawa (2012) found that
some of the isolated terpenoids from liverworts had antiHIV inhibitory properties. Fissidens nobilis (Figure 48) is
useful for jaundice (Asakawa 2015).
Stones
In the western Himalayans, native people use
Wiesnerella denudata (Figure 17) to treat gall stones
(Kumar et al. 2007). In China, Polytrichum commune
(Figure 4) is boiled to make a tea that reputedly helps to
dissolve stones of the kidney and gall bladder (Gulabani
1974; Chandra et al. 2017). Asakawa (2015) reported that
Conocephalum conicum (Figure 18) is useful in treating
gallstones.
Figure 19. Circular formations of Riccia species, such as
this Riccia austinii, suggested their use for curing ringworm,
according to the Doctrine of Signatures. Photo by Janice Glime.

Figure 17. Wiesnerella denudata, a liverwort used to treat
gall stones in the western Himalayas. Photo by Jan-Peter Frahm,
with permission.

Figure 20. Tinea (ringworm) on arm. Photo by Grook Da
Oger, through Creative Commons.

Figure 18. Thallose liverwort, Conocephalum conicum, one
of the thallose liverworts used to treat gallstones, bites, boils,
burns, cuts, eczema, and wounds. Photo by Janice Glime.

Ringworm
Riccia spp. (Figure 19) were ground to a paste and
used in the Himalayas to treat ringworm (Tinea spp., a
fungus; Figure 20) because of the resemblance of the
growth habit of those liverworts to the rings made by the
fungus (Shirsat 2008; Chandra et al. 2017). Recent tests on
Riccia fluitans (Figure 21) from Florida indicated no
ability to inhibit growth of bacteria [Pseudomonas
aeruginosa (Figure 22), Staphylococcus aureus (Figure
23)] or yeast (Candida albicans; Figure 24) (Pates &
Madsen 1955). Might Riccia species do any better with
ringworm?

Figure 21. Riccia fluitans, a floating aquatic liverwort that
seems to lack antibiotic properties. Photo by Jan-Peter Frahm,
with permission.
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Heart, Blood, and Cardiovascular Medicine
In China, 30-40 species of bryophytes may be found
on the shelves of the local pharmacist (Ding 1982). Among
the more common ones are Rhodobryum giganteum
(Figure 25, Figure 30) and R. roseum (Figure 26), used to
treat nervous prostration and cardio-vascular diseases, the
latter being a use that may have scientific merit (Wu 1982).
Among these uses is the treatment of hypertension (high
blood pressure) with R. giganteum (Wu 1977; Pant 1998;
Asakawa 2007b, 2015; Chandra et al. 2017).

Figure 22. SEM of Pseudomonas aeruginosa, a bacterial
species that is not inhibited by Riccia fluitans. Photo by Janice
Haney Carr, through Creative Commons.

Figure 25. Rhodobryum giganteum, a species widely used
medicinally in Yunnan, China. Photo by David Long, with
permission.

Figure 23. SEM of Staphylococcus aureus, a bacterium that
is not inhibited by Riccia fluitans. Photo by NIAID, through
Creative Commons.

Figure 26. Rhodobryum roseum, a species that is used to
treat nervous prostration and cardio-vascular diseases in China.
Photo by Michael Lüth, with permission.

Figure 24. Candida albicans, a yeast species that is inhibited
by extracts of the liverworts Conocephalum conicum,
Marchantia polymorpha, and Plagiochasma appendiculatum,
but not Riccia fluitans. Photo from Public Health Image Library,
through public domain.

In 1977, Wu reported the use of Rhodobryum
giganteum (Figure 25, Figure 30) to cure cardiovascular
disease in China. Chinese scientists have attempted to
demonstrate the basis for the healing powers of some of the
mosses, including Rhodobryum giganteum, used in ancient
treatments in China (Ding 1982). Going directly to the
peasants in east Szechuan, the staff of the Laboratory of the
Fourth Medical School in China learned about mosses used
by the peasants (Wu 1982). Through clinical research, they
successfully demonstrated that an ether extract of
Rhodobryum giganteum, used by these peasants to cure
angina, contains volatile oils, lactones, and amino acids;
when given to white mice, the extract actually reduced the
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oxygen resistance by increasing the rate of flow in the aorta
by over 30%. Is it time to replace ACE inhibitors, calcium
channel blockers, and beta blockers and their side effects?
The term Hui Xin Cao in Yunnan refers to the medical
effect of Rhodobryum species, meaning "return-the-heartherb" (Harris 2008). The Chinese use R. roseum (Figure
26), R. giganteum (Figure 25, Figure 30), and R.
ontariense (Figure 27). Unfortunately, the term Hui Xin
Cao refers to other plants as well (remember that the name
refers to its use, not its morphology), including the moss
Pogonatum cirratum (Figure 28) and the shrub Ledum
(Figure 29). Members of the genus Rhodobryum are used
in Yunnan for minor heart problems (Harris & Yang 2009).
Usage depends on location, not on gender, occupation, or
ethnicity. And its use also occurs in both rural areas and in
traditional Chinese medicine hospitals and medical
colleges.

antihypertensive effect of R. ontariense (Figure 27) in vivo
and attempted to find the mechanism used by R. ontariense
in controlling hypertension (Pejin et al. 2012e). They were
able to eliminate any effect on human erythrocyte
membrane fluidity, there was no reservoir of nitric oxide in
the blood, and there was only low ABTS cation scavenging
activity and little content of phenolic contents. The actual
mechanism remains elusive.

Figure 29. Ledum sp., a shrub with the same Chinese name
as Pogonatum cirratum and several species of Rhodobryum
because they are all used to treat heart problems. Photo by
Meggar, through Creative Commons.
Figure 27. Rhodobryum ontariense, a species used in China
to treat the heart. Photo by Janice Glime.

Figure 28. Pogonatum cirratum, a species used in China to
treat the heart. Photo by Li Zhang, with permission.

These reports of traditional usage were supported by a
number of studies on Rhodobryum. giganteum (Figure 25,
Figure 30) that demonstrated its usefulness in treating
cardiovascular problems and illustrating the physiological
mechanisms involved (Yu & Ma 1993; Yu et al. 1994,
1995; Yan et al. 1998; Lei et al. 2001a, b; Gao et al. 2004;
Zhou et al. 2004; Wang et al. 2005; Dai et al. 2006; Hu et
al. 2009). Pejin et al. (2011a, 2012c) reported on the

Masanobu Higuchi (Bryonet, 20 November 2006)
reports that when he stayed in Zhong Dian, northwestern
Yunnan, China, in 1994, he saw local people selling herbal
medicines by the roadside. Among these was the moss
Rhodobryum giganteum (Figure 25, Figure 30) in dry
condition, a traditional Tibetan medicine for heart trouble.
It was selling for US $0.50 per 10g. The same species is
used in the Himalayas as a neurologial and cardiac activant
(Kumar et al. 2007).
As already noted, their use as medical plants has made
Rhodobryum species the subject of a number of
biochemical studies, revealing a variety of biochemical
constituents in R. ontariense (Figure 27) [fatty acids
9,12,15-octadecatrien-6-ynoic and α-linolenic acid, having
known heart protective activity (Pejin et al. 2012a); 1kestose, a "health promoter" (Pejin et al. 2012b ); shortchain fructooligosaccharides, well known as prebiotics
(Pejin et al. 2012e). Thirteen essential oils have been
identified in R. ontariense (Pejin et al. 2011b), but their
roles in efficacy of Chinese medicine still remain to be
determined.
But wait! Mosses are known accumulators of heavy
metals, and we know that high amounts of these are
dangerous to human health. Pejin et al. (2012d) tested
Rhodobryum ontariense (Figure 27) for its heavy metal
content. Fortunately, they found that the concentrations of
arsenic, cadmium, chromium, copper, iron, lead, mercury,
nickel, manganese, and zinc in these mosses used in tea
were at safe levels for a typical daily intake of the tea.
They suggested that manganese was one of the important
components in treating hypertension. Nevertheless, these
results do not mean that the Chinese populations and
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species are safe as the heavy metal concentrations vary by
locations and distance from pollution source.
Lisu women in Yunnan Province, China, hike to fens
in the alpine area above the Salween River Valley (Nu
Jiang) to collect large amounts of Sphagnum (Figure 10),
which they subsequently dry (James Shevock, Bryonet, 16
January 2007). Despite about 27 species of Sphagnum
reported in Yunnan, these Lisu women (one of several
minority peoples in Yunnan Province) seem able to
recognize a particular species in the field; they claim that it
is only this species that is used for medicinal purposes.
This species of Sphagnum is used as a heart tonic,
probably brewed like a tea. Once dried and packaged, the
moss was to be exported to Canada! (Surely Canada has
more Sphagnum than Yunnan?)
Figure 32. Reboulia hemisphaerica, a species used in India
to stop bleeding. Photo by Jan-Peter Frahm, with permission.

Figure 30. Dried Rhodobryum giganteum (left container) at
a shop in Yunnan, China. Photo by David Long, with permission.

In India, bryophytes have also been used to treat heart
disease. One such treatment is with Cratoneuron filicinum
(Figure 31) (Pant 1998; Asakawa 2015; Chandra et al.
2017).
Figure 33. Funaria hygrometrica, a species used in India to
stop bleeding. Photo by Michael Lüth, with permission.

Figure 31. Cratoneuron filicinum, a species used in India to
treat the heart. Photo by Barry Stewart, with permission.

The Indians have also used several bryophytes to stop
bleeding. These include the thallose liverwort Reboulia
hemisphaerica (Figure 32) and the mosses Funaria
hygrometrica (Figure 33), Plagiomnium cuspidatum
(Figure 34), Polytrichum commune (Figure 4),
Pogonatum cirratum (Figure 28), and Taxiphyllum
taxirameum (Figure 35) (Gulabani 1974; Ding 1982; Pant
1998; Asakawa 2007b, 2015; Azuelo et al. 2011; Alam
2012; Shirsat 2008; Chandra et al. 2017).

Figure 34. Plagiomnium cuspidatum, a species used in
India to stop bleeding. Photo by Hermann Schachner, through
Creative Commons.
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Neurological Conditions

Figure 35. Taxiphyllum taxirameum, a species used in India
to stop bleeding. Photo by Michael Lüth, with permission.

Nosebleeds

Few bryophytes seem to be used for neurological
conditions. Nevertheless, in Cambridge, England, the moss
Homalothecium sericeum (Figure 36) from skulls has been
used in the treatment of epilepsy (Belcher & Swale 1998).
In China, liverworts have been used to treat convulsions,
neurasthenia (emotional disturbance typically involving
lassitude, fatigue, headache, and irritability), and other
nerve conditions (Asakawa 2012). Rhodobryum roseum is
useful for treating neurasthenia (Asakawa 2015).
Several bryophytes have been used to treat pain. For
Leucobryum bowringii (Figure 37), a paste is made of leaf
tips mixed in a cup of Phoenix sylvestris (silver date palm)
to treat pain (Lubaina et al. 2014; Chandra et al. 2017).
Oreas martiana (Figure 38) is used as an anodyne for
treating pain (Asakawa 2007b, 2015; Chandra et al. 2017).
These authors also reported the use of Oreas martiana to
treat nervosism and nervous exhaustion as well as epilepsy.
Ditrichum pallidum (Figure 39) has been used in India to
treat convulsions, especially in infants (Pant 1998;
Asakawa 2007b, 2015; Chandra et al. 2017).

One odd choice is the use in Cambridge of
Homalothecium sericeum (Figure 36) from skulls used to
treat nosebleeds, with recorded records as early as 1537
(Belcher & Swale 1998). The skulls were placed in damp
places to cultivate this moss. But other researchers
concluded that the tale was concocted and that no
medicinal value was present (Scott 1988). On the other
hand, Robert Boyle used it effectively on his own
nosebleeds. Perhaps it is just a good absorbent.

Figure 37. Leucobryum bowringii, a species used to treat
pain. Photo through Creative Commons.

Figure 36. Homalothecium sericeum from skulls is used to
treat nosebleeds in Cambridge. Photo by Michael Lüth, with
permission.

In another context, Plagiomnium cuspidatum (Figure
34) has been used to treat nosebleeds in India (Pant 1998;
Asakawa 2007a, 2015). This casts suspicion on my
suggestion of absorbency as this species does not rehydrate
easily. On the other hand, as already noted, Asakawa
(2015) reported that the mosses Funaria hygrometrica
(Figure 33), Oreas martiana (Figure 38), Polytrichum
commune (Figure 4), and Taxiphyllum taxirameum
(Figure 35) and the liverwort Reboulia hemisphaerica
(Figure 32) stop bleeding.

Figure 38. Oreas martiana, a species used to treat pain.
Photo by Michael Lüth, with permission.
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Figure 39. Ditrichum pallidum on the forest floor. This
species has been used in India to treat convulsions in infants.
Photo by Janice Glime.
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Figure 41. Bryum capillare with capsules, a moss used by
Seminole native people in North America to treat body aches and
fever. Photo by Michael Lüth, with permission.

Inflammation and Fever
Today we have freezers and use cold packs to soothe
inflammation and reduce fevers, but not so long ago those
conveniences were not available. Instead, Polytrichum
commune (Figure 4) has been used in China to reduce
inflammation and fever (Ding 1982; Chandra et al. 2017),
and the Seminole native people in North America used the
small mosses Barbula unguiculata (Figure 40) and Bryum
capillare (Figure 41), as well as larger mosses like
Octoblepharum albidum (Figure 42), as external
applications for fever and body aches (Sturtevant 1954;
Chandra et al. 2017). Barbula indica (Figure 43) and
Weissia controversa (Figure 44) have also been used in the
Western Ghats to treat intermittent fever (Lubaina et al.
2014). Taxiphyllum taxirameum (Figure 35) is an antiinflammitory (Asakawa 2015).

Figure 40. Barbula unguiculata, a moss used by Seminole
native people in North America to treat body aches and fever.
Photo by Bob Klips, with permission.

Figure 42. Octoblepharum albidum, a moss used by
Seminole native people in North America to treat body aches and
fever. Photo by Niels Klazenga, with permission.

Figure 43. Barbula indica, a moss used in the Western
Ghats to treat fever. Photo by Li Zhang, with permission.
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(Figure 44) and the thallose liverworts Conocephalum
conicum (Figure 18) and Marchantia polymorpha (Figure
5) are likewise antifever agents.

Figure 44. Weissia controversa, a moss used in the Western
Ghats to treat fever. Photo by Michael Lüth, with permission.

Fontinalis antipyretica (Figure 45) reputedly got its
specific name from its ability to work against fever, as
recorded in the journal of Linnaeus (Nils Cronberg, pers.
comm.). Drobnik and Stebel (2014) found that its use
against fever is reported in pre-Linnaean bryophyte floras
of central Europe. However, many people have interpreted
the name to be derived from its use to insulate chimneys
against fire, where in actuality it seems to have little value.
On the other hand, it may reduce the heat penetrating into
the house. But does it reduce fever? Perhaps it can serve
as a cool poultice.

Figure 46. Leptodictyum riparium, a moss used to treat
fever in India. Photo by David T. Holyoak, with permission.

Figure 47. Bryum argenteum, a moss used to treat fever in
India. Photo by Tushar Wankhede, through Creative Commons.

Urinary and Bowel Treatments
Figure 45. Fontinalis antipyretica, reported by Linnaeus as
being used to treat fever. Photo by Michael Lüth, with
permission.

Sabovljević et al. (2011) reported the use of
Marchantia palacea (Figure 16) to reduce swelling and
bring down fever. Leptodictyum riparium (Figure 46), an
aquatic moss, Philonotis fontana (Figure 62), a wetland
moss, and the cosmopolitan moss Bryum argenteum
(Figure 47) are used to treat fever in India (Pant 1998;
Asakawa 2007b, 2015; Chandra et al. 2017).
Octoblepharum albidum (Figure 42) was considered in
India to have similar ability to reduce fever (Singh 2011;
Chandra et al. 2017).
The mosses Haplocladium
capillatum (see Figure 52) and Leptodictyum riparium,
Polytrichum commune (Figure 4), Rhodobryum
giganteum (Figure 25, Figure 30), and Weissia controversa

The Chinese also use Polytrichum commune (Figure
4) as a detergent diuretic, laxative, and hemostatic agent
(Ding 1982; Ando & Matsuo 1984; Hu 1987; Fan et al.
2004; Harris 2008). In India, Fissidens nobilis (Figure 48)
and Dawsonia longifolia (Figure 49) are used as diuretics
(Pant 1998; Azuelo et al 2011; Chandra et al. 2017), and
Asakawa (2015) reports Marchantia polymorpha (Figure
5) for the same purpose. Pogonatum cirratum (Figure 28)
has been used as a laxative in India (Azuelo et al. 2011;
Alam 2012; Chandra et al. 2017). Asakawa (2015) reports
Fissidens nobilis (Figure 48) as a diuretic and
Haplocladium capillatum (see Figure 52) for treatig
cystitis and uropathy. Leptodictyum riparium (Figure 46)
and Rhodobryum giganteum (Figure 25, Figure 30)
likewise are used to treat uropathy (restricted urine flow)
(Asakawa 2015).
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and astringent (Azuelo et al. 2011; Alam 2012; Chandra et
al. 2017). In both China and India, cystitis (inflammation
of the bladder) has been treated with the moss
Haplocladium microphyllum (Figure 52) (Ding 1982; Pant
1998).

Figure 48. Fissidens nobilis, a species that is used as a
diuretic in India. Photo by Jan-Peter Frahm, with permission.
Figure 51. The leafy liverwort Herbertus sendtneri. Some
members of the genus Herbertus are used in India as a filter for
smoking. Photo by Michael Lüth, with permission.

Figure 49. Dawsonia longifolia, a species used as a diuretic
in India. Photo by Jan-Peter Frahm, with permission.

I was surprised to find Polytrichum juniperinum
(Figure 50) listed in Materia Medica as a treatment for
painful urination of the elderly, obstruction or suppression,
and dropsy (Available Materia Medicas 2011). The
medicine is made by boiling two ounces of the moss in a
liter of water until it boils down to only half that – a pint,
making a "tincture." One dose (4 ozs, 113 g) should be
taken every 8 hours.

Figure 52. Haplocladium microphyllum, a species that is
used to treat bladder infections in China and India. Photo by
Robin Bovey, with permission through Dale Vitt.

Gynecology
The absorbent properties that make Sphagnum (Figure
10) an excellent bandage also make it suitable for diapers
and sanitary napkins, a product currently sold by Johnson
and Johnson Company (D. H. Vitt, pers. comm.).

Figure 50. Polytrichum juniperinum, a hairy cap moss, is
used in China to treat urinary and prostate problems. It can be
recognized by the brown tips on the leaves and the rolled over leaf
edges that cover the lamellae. Photo by Michael Lüth, with
permission.

The leafy liverwort Herbertus sp. (Figure 51) is used
in India as an antiseptic, antidiarrheal agent, expectorant,

Figure 53. Sphagnum Sanitary napkin. Photo from National
Museum of American History, with online permission.
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Sphagnum (Figure 10) has also been used, along with
grass, sponge, and other plant fiber, as a contraceptive to
block the entry of sperm (Stanley 1995). By contrast,
following successful pregnancies, the Nitinaht peoples of
Vancouver Island, Canada, used Polytrichum commune
(Figure 4) as a gynecological aid (Turner et al. 1983;
Chandra et al. 2017). Women in labor chewed the moss to
speed up the labor process.
In China, Polytrichum (Figure 4, Figure 50) has been
used to stop bleeding and night sweats, presumably
associated with menopause (EBCHSATCM 1999; Cheng et
al. 2008; Fu et al. 2009). It has also been used to treat
uterine prolapse (the uterus sags due to weakening of
muscles or ligaments that support it).
The moss Oreas martiana (Figure 38) is used to treat
menorrhagia (prolonged bleeding with menstrual period)
(Asakawa 2007b; Chandra et al. 2017). Barbula indica
(Figure 43) has been used in the Western Ghats to treat
menstrual pain (Lubaina et al. 2014; Chandra et al. 2017).

Figure 56. Atrichum undulatum. Some members of this
genus are used in medicines in China. Photo by Michael Lüth,
with permission.

Disinfectant and Infections
The Native American Nitinahts also used Sphagnum
(Figure 10) as a disinfectant (Turner et al. 1983).
Fissidens (Figure 54) is used in China as an antibacterial
agent for swollen throats and other symptoms of bacterial
infection, and in Bolivia it likewise has medicinal uses.
Judith Sullivan (Bryonet, 16 January 2007) reported seeing
labels on Chinese medicines that included Grimmia (Figure
55), Atrichum (Figure 56), Polytrichum (Figure 4, Figure
50), and Thuidium (Figure 57), primarily as anti-bacterial
and anti-inflammatory agents. Polytrichum juniperinum
(Figure 50) is used there for some prostate and urinary
difficulties.

Figure 57. Thuidium recognitum. Some members of
Thuidium are used as anti-bacterial and anti-inflammatory agents
in China. Photo by Jan-Peter Frahm, with permission.

Dried Sphagnum (Figure 58) is sold to treat
hemorrhages (Bland 1971), and S. teres (Figure 58) is used
to treat eye diseases and hemorrhoids (Ding 1982).
Haplocladium microphyllum (Figure 52) is sold to treat
bronchitis, tonsillitis, and tympanitis, as well as cystitis
(Ding 1982).
Figure 54. Fissidens osmundoides, a moss in one genus
used as an antibacterial agent to treat sore throats in Bolivia and
several Asian countries. Photo by Michael Lüth, with permission.

Figure 55. Grimmia pilifera, a Chinese species. Some
members of this genus are used in medicines in China. Photo by
Henk Greven, with permission.

Figure 58. Sphagnum teres is used to treat eye diseases in
Asia. Photo by Michael Lüth, with permission.
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As noted in Chapter 1 of this volume, the soap
Sphagnol is a Sphagnum (Figure 10; Figure 58) product
used to treat skin problems such as acne, eczema, chilblains
(painful inflammation of small blood vessels in the skin),
dandruff, insect bites, and ringworm (a fungus) (The
Science Museum 2012). This product was used during
both World Wars by the British Red Cross to treat facial
wounds and is believed to have antibiotic properties.
Kumar et al. (2007) reported on antibacterial species
used in India, as discussed in Chapter 2-2 on Biologically
Active Substances. Oreas martiana (Figure 38) and
Taxiphyllum taxirameum (Figure 35) likewise are used to
treat wounds (Asakawa 2015), perhaps having antibiotic
properties. the leafy liverwort Frullania tamarisci has
known antiseptic properties (Asakawa 2015).
Nose and Throat
In both India and North America, the moss Philonotis
fontana (Figure 62) has been used to treat
adenopharyngitis, an inflammation of the pharynx and
tonsils (Flowers 1957; Pant 1998; Asakawa 2007b;
Chandra et al. 2017). Haplocladium capillatum (see
Figure 52) and Philonotis fontana likewise can be used to
treat adenopharyngitis (Asakawa 2015).
Bryum
argenteum (Figure 47) and Weissia controversa (Figure
44) have chemical properties used to treat rhinitis
(inflammation of the mucous membrane of the nose)
(Asakawa 2015).
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Figure 59. Hyophila involuta drying. This species has been
used to treat cold, cough, and sore throat. Photo by Bob Klips,
with permission.

The other side of the coin is the ability of some
mosses, especially Sphagnum (Figure 58), to harbor fungi
that cause lung disease. Sphagnum was once thought to
harbor Mycobacteria (Figure 60), the genus in which the
tuberculosis bacterium resides, but now it seems that it is
not the reservoir for this genus it was thought to be (Deriu
et al. 1995). On the other hand, the fungus Sporothrix
schenckii (Figure 61), common on Sphagnum, does cause
pulmonary sporotrichosis, an infection of the lung
resulting from breathing the fungi (McCain & Buell 1968).

Lung Diseases
Funaria hygrometrica (Figure 33) has been used in
India to treat pulmonary tuberculosis (Pant 1998; Chandra
et al. 2017), and Asakawa (2015) indicates it has
compounds useful for that purpose, as does Polytrichum
commune (Figure 4). The similarity of Marchantia
polymorpha (Figure 5) thalli to the texture of lung tissue
caused Europeans to use that liverwort to treat pulmonary
tuberculosis (Bland 1971). It is likely that this Doctrine of
Signatures was also responsible for the Chinese use of
liverworts to treat pulmonary tuberculosis (Asakawa 2012).
It is interesting that its thallus has been interpreted as
resembling both liver tissue and lung tissue.
In Cambridge, England, the moss Homalothecium
sericeum (Figure 36) was used to treat whooping cough
(Belcher & Swale 1998). In the Himalayas the moss
Haplocladium microphyllum (Figure 52) is used to treat
bronchitis (Kumar et al. 2007).
Haplocladium
microphyllum has also been used to treat tonsillitis and
pneumonia (Ding 1982; Pant 1998; Chandra et al. 2017);
H. capillatum (see Figure 52) is known for its use in
treating in pneumonia (Asakawa 2015).
Treatments of colds, not surprisingly, has made use of
bryophytes. Hyophila involuta (Figure 59) has been used
for the symptoms of a cold, cough, and sore throat. This
treatment is a leaf decoction with a pinch of ground pepper,
used daily (Lubaina et al. 2014; Chandra et al. 2017). Also
in India, natives in the Western Ghats have used Weissia
controversa (Figure 44) to treat colds.

Figure 60. Mycobacterium tuberculosis SEM, member of a
pathogenic genus once thought to live among Sphagnum. Photo
from NIAID, through Creative Commons.

Figure 61. Sporothrix schenckii conidia, a species that
grows among Sphagnum and causes sporotrichosis. Photo from
USDHHS, through public domain.
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Skin Ailments and Burns
The antibiotic properties of many bryophytes suggest
that they should promote healing of skin infections. The
thallose liverwort Reboulia hemisphaerica (Figure 32) is
used to treat skin blotches, external wounds, and bruises
and Oreas martiana (Figure 38) is used to treat external
wounds (Asakawa 2007b, 2015; Chandra et al. 2017).
Fissidens nobilis, Conocephalum conicum (Figure 18),
and Marchantia polymorpha (Figure 5) have compounds
that help in the healing of burns (Asakawa 2015). Funaria
hygrometrica (Figure 33) is useful in treating bruises and
Athlete's foot. Rhodobryum giganteum (Figure 25, Figure
30), Conocephalum conicum, and Marchantia
polymorpha can be used to treat cuts (Asakawa 2015).
Himalayan Indians use a mixture of moss ashes with
fat and honey to soothe and heal cuts, burns, and wounds
(Pant et al. 1986; Pant 1998; Chandra et al. 2017), claiming
that these ashes heal wounds more quickly (Pant & Tewari
1989). Taxiphyllum taxirameum (Figure 35) is among
those mosses used to treat surface wounds (Pant 1998;
Asakawa 2007b; Chandra et al. 2017). In the Himalayas,
the Gaddi tribe uses Philonotis fontana (Figure 62) and
Plagiochasma appendiculatum (Figure 63) to treat burns
and skin diseases (Flowers 1957; Pant 1998; Asakawa
2007b; Kumar et al. 2007; Shirsat 2008; Alam 2012;
Chandra et al. 2017). Bryum thomsonii is used in the
Northwest Himalayas for healing wounds (Kumar et al.
2007).
Himalayan Indians have used Marchantia
polymorpha (Figure 5; Figure 64) or M. palmata to treat
boils and abscesses because the young archegoniophore
resembles a boil as it emerges from the thallus (Pant &
Tewari 1989).

This paste is smeared over the body of the children affected
by itching skin, scabies, and other skin diseases (Remesh &
Manju 2009; Chandra et al. 2017).

Figure 63.
Plagiochasma appendiculatum with
archegoniophores, a species used in the Himalayas to treat burns
and skin diseases. Photo by Michael Lüth, with permission.

Figure 64.
Young archegoniophores of Marchantia
polymorpha, somewhat resembling a boil. Photo by Rudolf
Macek, with permission.
Figure 62. Philonotis fontana is a wetland moss used by
Gosuite native people to relieve pain of burns. Photo by Michael
Lüth, with permission.

In India, the pendent moss Aerobryum lanosum is
used to treat burns. The whole plant is boiled in goat urine
and applied externally (Lubaina et al. 2014; Chandra et al.
2017). Species of Mnium (sensu lato?) (Figure 3) have
been used in a poultice to reduce pain from bruises,
wounds, and burns (Azuelo et al. 2011; Chandra et al.
2017). Similarly, these authors found that Plagiomnium
(Figure 12, Figure 34) has been used for treating infections
and swellings.
Also in India, the thallose liverwort Targionia
hypophylla (Figure 65) is used, mixed with leaves of the
flowering plant Actiniopteris radiata, and ground into a
paste, then mixed with two tablespoons of coconut oil.

Figure 65. Targionia hypophylla, a species used in India to
treat skin diseases. Photo by Martin Hutten, with permission.
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Marchantia palmata is made into a fleshy leaf paste
and applied directly to acute inflammation caused by heat
(burns) (Tag et al. 2007; Chandra et al. 2017).
Another skin-related use in India is that of the
cosmopolitan moss Funaria hygrometrica (Figure 33) to
treat bruises and skin infections (Pant 1998; Chandra et al.
2017).
Among the Native Americans, the Cheyenne in
Montana use Polytrichum juniperinum (Figure 50) in
medicines (Hart 1981). In Utah, USA, the Gosuite native
peoples used Bryum (Figure 41, Figure 47), Mnium
(Figure 3), Philonotis (Figure 62), and various matted
hypnaceous forms crushed into a paste applied to reduce
the pain of burns, bruises, and wounds (Flowers 1957).
Sphagnum (Figure 10) was used by Native Americans as a
carrier for berries that were rubbed on children's sores
(Carrier Linguistic Committee 1973).
As one might expect, the Chinese have used liverworts
in the treatment of skin ailments, including cuts, burns, and
bruises (Asakawa 2012). A mixture of the thallose
liverworts Conocephalum conicum (Figure 18) and
Marchantia polymorpha (Figure 5) with vegetable oils is
used in China on bites, boils, burns, cuts, eczema, and
wounds (Wu 1977; Ding 1982; Ando 1983; Yan et al.
1999).
In China and India, Conocephalum conicum (Figure
18) has a number of medical uses. Its antimicrobial,
antifungal, antipyretic, and antidotal activities contribute to
its usefulness to treat cuts, swollen tissue, scalds, burns,
fractures, and poisonous snake bites (Ding 1982; Alam
2012; Chandra et al. 2017). Likewise, Marchantia
polymorpha (Figure 5) has been used to treat snake bites
(Hu 1987; Shirsat 2008; Azuelo et al. 2011; Asakawa
2015; Chandra et al. 2017). Bryum argenteum (Figure
47), Polytrichum commune (Figure 4), and one or more
species of Philonotis (Figure 62) have been used as
antidotes (Asakawa 2007b, 2015; Chandra et al. 2017).
Alaskan native peoples have used Sphagnum (Figure
10), mixed with fat, to make a salve (Schofield 1969;
Miller & Miller 1979). In Britain Sphagnum was used to
treat boils (Bland 1971), its derivative sphagnol to relieve
the itch of a mosquito bite (Crum 1988), and for medicinal
baths (Crum 1973; Weber & Ploetner 1976; Turner 1993),
although the small amounts of active substances put into an
average bath are not likely to have any effect.
Nevertheless, Mitchell and Rook (1979) caution us
about the possible allergenic effects of Sphagnum (Figure
10), especially because of its ability to harbor the fungus
causing sporotrichosis (Adams et al. 1982). It is a known
danger to nursery workers and harvesters who are in
constant contact with the Sphagnum (D'Alessio et al.
1965; McCain & Buell 1968; Tamblyn 1981; Keller 1988;
Padhye & Ajello 1990; Coles et al. 1992), even affecting
areas like the abdomen (Frankel & Frankel 1982). In 1988,
sporotrichosis reached sufficient proportions that
"Sphagnum the culprit" made its debut in the Milwaukee
Journal (Rosenberg 1988). In 1995, nine of the 65 workers
involved in making topiary art at a Florida nursery became
infected with lymphocutaneous sporotrichosis (Hajjeh et al
1997). Even forestry workers who don't handle the moss
directly can contract the disease from working in peatlands
(Powell et al. 1978). The threat is sufficient to cause the
American Orchid Society to warn its members of this
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occupational hazard (Padhye & Ajello 1990).
The
Macauley Institute in Aberdeen, England, is investigating
the use of hydroponics to produce Sphagnum that is free of
microorganisms and other contaminants. Wearing gloves
helps to protect against the lymphocutaneous sporotrichosis
(Hajjeh et al. 1997), but longer exposures can still lead to
pulmonary infections.
Eye Problems and Diseases
In the northwest Himalayas, Sphagnum teres (Figure
58) is used to treat ophthalmic diseases (Kumar et al.
2007). There seems to be medical evidence that at least
some of the bryophytes can be used effectively to treat agerelated blindness (age-related macular degeneration)
(Albert-Ludwigs-Universität Freiburg 2010). Factor H is
necessary to maintain healthy eyes (Coffey 2007). The
Freiburg research lab has produced a protein in a bioreactor
using factor H from mosses. Factor H is otherwise known
only from blood and is important for the immune system.
50 million people suffer blindness due to lack of this
protein, especially in industrial countries.
Büttner‐Mainik et al. (2011) developed a protocol to
produce Factor H using Physcomitrella patens (Figure 6,
Figure 7). Factor H is a protein that is difficult to produce
in animal lines, but these researchers successfully produced
it in transgenic P. patens.
Flatbergium sericeum (Figure 66), a relative of
Sphagnum, has been used to treat eye diseases (Azuelo et
al. 2011; Chandra et al. 2017). Similarly, Sphagnum teres
(Figure 58) has been used for this purpose in China (Ding
1982).

Figure 66. Flatbergium sericeum, a species that has been
used to treat eye diseases. Photo courtesy of Jon Shaw.

Ear Ache and Hearing Problems
Entodon flavescens is used by the Kani tribes in the
Western Ghats for treating ear ache (Lubaina et al. 2014;
Chandra et al. 2017). They use a leaf juice as ear drops,
especially in cold weather. Haplocladium capillatum (see
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Figure 52) has been used to treat tinnitis, but recent news
reports suggest this is not really related to the ears.
Hair Treatments
Soothing a wound of a different sort (human pride), the
Chinese use Fissidens (Figure 54; Figure 79), burned, to
put on their heads to encourage hair growth! (Harris 2002).
In India, Fissidens nobilis (Figure 48) has likewise been
used to grow hair (Pant 1998; Azuelo et al. 2011). And
Asakawa (2015) found compounds in Fissidens nobilis
(Figure 48) that should promote hair growth
Most likely following the Doctrine of Signatures,
Himalayan natives use Polytrichum commune (Figure 4)
to promote hair growth (Kumar et al. 2007). The Doctrine
of Signatures is a theory that the plant tells us what it is
useful for by its morphology or other properties. Since
Polytrichum commune has a hairy calyptra (Figure 67),
that would suggest it is good for growing hair. Similarly,
the hairs on the calyptra most likely account for the use of
Dawsonia longifolia (Figure 69) to grow hair (Azuelo et
al. 2011; Chandra et al. 2017).

Figure 69. Dawsonia longifolia with capsule, showing long
hairs on the calyptra. Photo by Vita Plasek, with permission.

Figure 67. Polytrichum commune capsules with hairy
calyptrae (and one with calyptra removed). This species is used
to help grow hair. Photo by Michael Lüth, with permission.

Frullania ericoides (Figure 68) is used to treat the hair
and scalp in India (Remesh & Manju 2009; Chandra et al.
2017). It purportedly gets rid of head lice and nourishes
the hair.

Figure 68. Frullania ericoides, a species used in India to
treat the hair and scalp. Photo by Paul Davison, with permission.

Sedatives
The use of bryophytes as sedatives seems to be
uncommon. The moss Hypnum (Figure 70) was named for
sleep, but that is because it was used to stuff pillows, not
for any known sedative effect (Dillenius 1741). However,
Plagiopus oederianus (Figure 71) has been used in India as
a sedative, as well as for treating epilepsy (Pant 1998;
Asakawa 2015; Chandra et al. 2017). And the widely used
Rhodobryum roseum and R. giganteum (Figure 26)
likewise have been used as sedatives (Wu 1977; Pant 1998;
Asakawa 2007b, 2015; Chandra et al. 2017).

Figure 70. Hypnum cupressiforme, a moss that filters
substances out of items for smoking and is used to stuff pillows.
Photo by Michael Lüth, with permission.
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Figure 71. Plagiopus oederianus, a species used in India as
a sedative and to treat epilepsy. Photo by Michael Lüth, with
permission.

Antidotes
The mosses Bryum argenteum (Figure 47),
Haplocladium capillatum (see Figure 52). Philonotis
fontana (Figure 62), Polytrichum commune (Figure 4),
and Weissia controversa (Figure 44) can be used as an
antidote, as well as Conocephalum conicum (Figure 18)
and Marchantia polymorpha (Figure 5). But Asakawa
does not state what things these will treat (Asakawa 2015).
For Conocephalum conicum, Asakawa reports that it can
be used to treat snake bites.

Figure 73. Meteoriopsis squarrosa, a pendent species in the
Western Ghats. The genus Meteoriopsis is used as a smoking
filter in the Himalayas. Photo by M. C. Nair, K. P. Rajesh, and P.
V. Madhusoodanan, through Creative Commons.

Filters
Kumaun Indians (also Kumaon) of the Himalayas use
slender bryophytes such as Herbertus (Figure 51),
Anomodon (Figure 72), Entodon (Figure 76), Hypnum
(Figure 70), Meteoriopsis (Figure 73), and Scapania
(Figure 74), wrapped in a cone of Rhododendron
campanulatum (Figure 75) leaves, to serve as a filter for
smoking (Pant & Tewari 1989). One must wonder if any
of those heated phenolic compounds in bryophytes might
be as harmful as the substances they filter out!

Figure 74. Scapania gracilis. Members of this genus are
used as smoking filters in the Himalayas. Photo by Michael Lüth,
with permission.

Figure 72. Anomodon rugelii, a moss of vertical surfaces,
filters substances out of items for smoking. Photo by Michael
Lüth, with permission.

Figure 75. Rhododendron campanulatum. Leaves of this
species are used to wrap bryophytes to serve as smoking filters.
Photo by Kurt Stüber, through Creative Commons.
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One peat product has actually entered modern
medicine as a means to cleanse the body of pollutants:
humic acids. HUMET-R syrup entered medicine as a
transporter of trace elements, reducing excess trace
elements that are bombarding the human body from
pollutants and other sources (Kleb et al. 1999). The active
substance is humin acid.

for the user because it is cooler, softer, less irritating, and
retards bacterial growth (Banerjee 1974). In fact, tests
indicate that the amount of wound area covered by new
epidermis doubles with use of Sphagnum dressing
compared to no dressing (Varley & Barnett 1987).

Figure 76. The pleurocarpous moss Entodon concinnus is
used as a smoking filter. Photo by Michael Lüth, with
permission.

Surgical and Larger Wounds
Bryophytes have been used both in treating and in
cushioning wounds. In Utah, the Gosuite native people
used poultices of Bryum (Figure 41, Figure 47), Mnium
(Figure 3), Philonotis (Figure 62), and various matted
hypnaceous forms as padding under splints to set broken
bones.
But it is Sphagnum (Figure 10) that has gained fame
for its use as a bandage (Figure 77) (Painter 2003). It
appears that even before the First World War, Sphagnum
was used to bandage the wounded in the Russo-Japanese
War (1904-05). In the First World War, the Americans
(USA) and Canadians used Sphagnum (peat moss) to make
bandages, conserving the valuable cotton for making and
packing gunpowder (Porter 1917; Hotson 1918, 1919,
1921; Nichols 1918a, b, c, d, 1920). The wounds
apparently healed better than those with sterile surgical
bandages, benefitting from the moisture and fewer
infections. The British Army used about 1,000,000 pounds
(453590 kg) of dressing per month (Nichols 1918c, 1920),
saving about US $200,000 (Bland 1971), the Canadian Red
Cross about 200,000 pounds (90720 kg) per month, and the
United States about 500,000 pounds (226800 kg) during the
last six months of war (Bland 1971). After the war, these
countries returned to traditional gauze bandages, but the
Chinese have continued to use Sphagnum for this purpose
(Ding 1982).
The superiority of Sphagnum (Figure 10) bandages is
attributed in part to its ability to absorb 3-4 times as much
liquid as a cotton bandage at a rate three times as fast
(Porter 1917). This is due to the interlaced hyaline cells
that are dead and possess pores (Figure 78). These cells
retain water and readily absorb water when dry. Hence, the
bandage retains liquids longer and more uniformly,
necessitating less frequent change. It is more comfortable

Figure 77. Sphagnum for surgical dressings. Photo from
National Museum of American History, with online permission.

This news article appeared on page 4 of The Seattle
Star (Washington, USA), 3 April 1918:
"U" STUDENTS TO MAKE 50,000 MOSS DRESSINGS
Fifty thousand sphagnum dressings, for use in France,
will be made at the University of Washington before June
15. The dressings will follow a new design and will be
submitted for experiment. If successful, it is expected that
a call will come for 50,000 each week.
Between 800 and 900 freshman and sophomore girls
are now registered for work on sphagnum moss dressings.

Figure 78. Stained cells of Sphagnum showing large hyaline
cells with pores and small photosynthetic cells. Photo and
drawings by Janice Glime.
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The pectin complex in the Sphagnum (Figure 78) cell
wall is similar structurally to immunostimulatory pectin
from tracheophytes that has traditionally been used for
healing wounds (Painter 2003).
Sphagnum (Figure 10) is not the only moss that has
been used for bandages. The Nitinaht native people of
Vancouver Island, Canada, used a moss known as
maidenhair moss (Fissidens adianthoides; Figure 79) to
bandage wounds. The Anglo-Saxons gave it the name of
maidenhair moss because to them it resembled a maiden's
pubic hair.
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absorb water. He found several that could rival Sphagnum
in absorptive ability (Table 1).
Table 1. Weight gain measured as wet weight to dry weight
ratio of selected bryophytes (Horikawa 1952).

Atrichum
6.9
Figure 56
Barbula
8.3 Figure 40, Figure 43
4.0
cf. Figure 81
Bazzania pompeana
Figure 82
Haplomitrium mnioides 12.0
cf. Figure 83
Loeskeobryum cavifolium 9.8
Figure 84
Plagiomnium maximoviczii 6.7
10.0
Figure 25
Rhodobryum
12.4
Figure 58
Sphagnum
Figure 85
Trachycystis microphylla 3.2

Figure 79. Fissidens adianthoides is the maidenhair moss
used by the Nitinaht native people for bandages. Photo by
Michael Lüth, with permission.

Perhaps one of the more unusual uses of liverworts is
the Chinese use to promote healing of fractures (Asakawa
2012); he reports Conocephalum conicum (Figure 18) and
Marchantia polymorpha (Figure 5) to be useful for this
(Asakawa 2015). Lubaina et al. (2014) reported the use of
the leafy liverwort Plagiochila beddomei (see Figure 80)
for healing wounds in the Western Ghats.

Figure 81. Bazzania trilobata. Bazzania pompeana gains
water up to 4 time its dry weight. Photo by Janice Glime.

Figure 80. Plagiochila sp. Plagiochila beddomei is used in
the Western Ghats for healing wounds. Photo by Lin Kyan, with
permission.

The use of Sphagnum (Figure 10) as a bandage is not
without its hazards, as mentioned earlier. Perhaps other
mosses may serve an absorptive function as well or better
than Sphagnum and impose fewer hazards. Horikawa
(1952) compared a number of mosses and their ability to

Figure 82. Haplomitrium mnioides, a species that gains
water up to 12 times its dry weight. Photo by Yang, Jia-Dong,
through Creative Commons.
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Figure 83. Loeskeobryum brevirostre. Loeskeobryum
cavifolium gains water up to 9.8 times its dry weight. Photo by
Bob Klips, with permission.

compound, Moss-aGal (Kirstein 2017). Six patients were
monitored for 28 days following a single dose of the
pharmaceutical and showed no negative effects. This is
only phase 1 of the study, but it provides promise in
relieving symptoms in patients suffering from Fabry
disease. This is the first moss-based clinical product to be
tested in humans. The research has been done at
Greenovation, a privately-owned biopharmaceutical
company based in Heilbronn, Germany. It was founded in
1999 by Prof. Dr. Ralf Reski and Prof. Dr. Gunter
Neuhaus.
Fabry disease is a rare genetic disease causing a
deficiency of the enzyme alpha-galactosidase A (a-Gal
A), hence the name Moss-aGal for the moss compound to
treat it. This disease causes a buildup of a type of fat called
globotriaosylceramide (Gb3, or GL-3) in the body. Fabry
disease is classified as a type of lysosomal storage disorder.
There is no known cure, only treatments of the deficiency.

Summary

Figure 84. Plagiomnium maximoviczii, a species that gains
water up to 6.7 times its dry weight. Photo through Creative
Commons.

Bryophytes have been traditionally used for their
medicinal properties in China, India, and among Native
Americans.
Their use in Europe became more
widespread following the development of the Doctrine
of Signatures. Among the most commonly used,
Marchantia polymorpha was used for liver ailments
and is still used in some places, but is also used for
boils and abscesses. Rhodobryum giganteum is used
for cardiovascular problems, a use supported by clinical
tests.
Traditional uses of bryophytes include treatment
for liver ailments, ringworm, heart problems,
inflammation, fever, urinary and digestive problems,
female problems, infections, lung disease, skin
problems, and as filters and cleansing agents against
pollutants.
The ability of Sphagnum to promote healing of
flesh wounds is well documented. Sphagnol is used to
treat boils and mosquito bites, and Sphagnum in
diapers prevents diaper rash.
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Figure 1. Bryophytes and other herbs on sale in a Yunnan, China, market. Rhodobryum giganteum (upper bag) and Leucobryum
(lower bag), both called Hui Xin Cao. Photo by courtesy of Eric Harris.

Antibiotics and Other Biologically Active Substances
Bryophyte species actually produce broad-range
antibiotics (Asakawa 2007a, b, 2008; Asakawa et al. 2013).
Their usage in surgical dressings, diapers, and other human
medicinal applications is well known. And their use has
not been confined to Asia (Frahm 2004), but is known in
Brazil (Pinheiro da Silva et al. 1989), England (Wren
1956), North America (Pejin et al. 2011a, b), and Germany

(Frahm 2004), as well as in China (Ding 1982; Wu 1982)
and India (Watts 1891). Frahm (2007) has reviewed the
literature on bryophytes and their antibiotic activity.
Bryophytes discourage the feeding by a variety of
organisms, as discussed in the chapters on terrestrial
insects, arthropods, and other interaction chapters. Frahm
and Kirchhoff (2002) showed that extracts of the epiphytic
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moss Neckera crispa (Figure 2) and leafy liverwort Porella
obtusata (Figure 3) both discouraged feeding by the
Portuguese slug Arion lusitanicus (Figure 4).
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skeletal acetogenins, phenolic compounds, and terpenoids
were identified. Testing of these compounds has led to the
commercial development of a natural pesticide (Frahm
2004).
Leptolejeunea (Figure 5) and Moerckia (Figure 6) are
distinctly aromatic (Schuster 1966), Lophozia bicrenata
(Figure 7) has a pleasant odor, species of Solenostoma
(Figure 8) smell like carrots, Geocalyx graveolens (Figure
9) has a turpentine-like odor, and Conocephalum conicum
(Figure 10) smells like mushrooms.
The tropical
Plagiochila rutilans (Figure 11) smells like peppermint,
caused by several menthane monoterpenoids (Heinrichs et
al. 2001).

Figure 2. Neckera crispa, a species that discourages the
Portuguese slug from eating it. Photo by Jan-Peter Frahm, with
permission.

Figure 5. Leptolejeunea elliptica, a species with a distinct
odor. Photo by Yan Jia-dang, through Creative Commons.

Figure 3. Porella obtusata, a species that discourages the
Portuguese slug from eating it. Photo by Michael Lüth, with
permission.

Figure 6. Moerckia flotoviana female, a species with a
distinct odor. Photo by Michael Lüth, with permission.

Figure 4. Arion lusitanicus, a slug that avoids eating
extracts of the moss Neckera crispa and leafy liverwort Porella
obtusata. Photo by Ondřej Zicha, through Creative Commons.

One indication of the presence of unique and
potentially important pharmaceutically and anti-feedant
chemicals in bryophytes is the presence of unique odors.
This is especially true for liverworts, with more than
several hundred new compounds identified among them
(Asakawa 2012). In addition, more than 40 new carbon

Figure 7. The leafy liverwort Lophozia bicrenata. Photo by
Michael Lüth.
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Figure 8. Solenostoma hyalina, a species that smells like
carrots. Photo by Janice Glime.

Figure 11. Plagiochila sp. Plagiochila rutilans smells like
peppermint. Photo by Lin Kyan, with permission.

It appears that these unique odors result from a
combination of many compounds, including monoterpene
hydrocarbons such as α-pinene, ß-pinene, camphene,
sabinene, myrcene, alpha-terpinene, limonene, fatty acids,
and methyl esters of low molecular weight (Hayashi et al.
1977). For example, Isotachis japonica (Figure 12) has at
least three aromatic esters:
benzyl benzoate, benzyl
cinnamate, and B-phenylethyl cinnamate (Matsuo et al.
1971).

Figure 9.
The leafy liverwort Geocalyx graveolens.
Underleaf is indicated by the red star. Photo by Michael Lüth.

Figure 12. Isotachis sp. Isotachis japonica has at least three
aromatic esters. Photo by George Shepherd, through Creative
Commons.

Figure 10. Conocephalum conicum, a species that smells
like mushrooms. Photo by Hermann Schachner, through Creative
Commons.

But can you imagine using mosses to lower your
cholesterol? Yes, mosses contain polyunsaturated fatty
acids that are already known to have important potentials in
human medicine, such as preventing atherosclerosis and
cardiovascular
disease,
reducing
collagen-induced
thrombocyte aggregation, and lowering triacylglycerols and
cholesterol in plasma (Radwan 1991).

But progress in purifying and identifying bryophyte
biochemical components and demonstrating their antibiotic
effects has been slow. As early as 1952, Madsen and Pates
found inhibition of microorganisms in products of
bryophytes, including Sphagnum portoricense (Figure 13),
S. strictum (Figure 14), Conocephalum conicum (Figure
10), and Dumortiera hirsuta (Figure 15) (see also
Sabovljević et al. 2011; Chandra et al. 2017). Pavletic and
Stilinovic (1963) found that Dicranum scoparium (Figure
16) strongly inhibited all bacteria tested but Gram-negative
Escherichia coli (Figure 17). McCleary and Walkington
(1966) considered that non-ionized organic acids and
polyphenolic compounds might contribute to the antibiotic
properties of bryophytes and found eighteen mosses that
strongly inhibited one or both of Gram-positive and Gramnegative bacteria, the most active being Atrichum (Figure
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20), Dicranum (Figure 16), Mnium (Figure 18),
Polytrichum (Figure 19), and Sphagnum. Reminiscent of
Dicranum scoparium (Figure 16), Atrichum undulatum
(Figure 20) was effective on everything tested except
Enterobacter aerogenes (drug resistant and infectious to
people with weak immune systems; Figure 21) and E. coli.

Figure 16. Dicranum scoparium, a species that inhibited all
bacteria tested but Gram-negative Escherichia coli. Photo by
Janice Glime.

Figure 13. Sphagnum portoricense, a species that inhibits
microorganisms. Photo by Blanka Shaw, with permission.

Figure 17. Escherichia coli, a species that is inhibited by
acetone-soluble extracts of several thallose liverwort species.
Photo by NIAID, through Creative Commons.
Figure 14. Sphagnum strictum, a species that inhibits
microorganisms. Photo by Jan-Peter Frahm, with permission.

Figure 15. Dumortiera hirsuta, a species that inhibits
microorganisms. Photo by Michael Lüth, with permission.

Figure 18. Mnium spinulosum. Members of the genus
Mnium are among the most active against one or both of Grampositive and Gram-negative bacteria. Photo by Michael Lüth,
with permission.

2-2-6

Chapter 2-2: Medical Uses: Biologically Active Substances

bibenzyls could inhibit growth of Staphylococcus aureus
(Figure 25) at concentrations of 20.3 µg ml-1. Out of more
than 80 species tested, Ichikawa (1982) and coworkers
(1983) found antimicrobial activity in nearly all. Acyclic
acetylenic fatty acid and cyclophentenonyl fatty acid
extracts from the mosses completely inhibited the growth
of the rice blast fungus Magnaporthe grisea (Figure 26).
Belcik and Wiegner (1980) reported antimicrobial activity
in extracts of the liverworts Pallavicinia (Figure 27) and
Reboulia (Figure 28), and Isoe (1983) reported it from
Porella (Figure 29).

Figure 19. Polytrichum commune. Members of the genus
Polytrichum are among the most active against one or both of
Gram-positive and Gram-negative bacteria. Photo by Michael
Lüth, with permission.

Figure 22. Barbula convoluta, member of a genus with high
antibacterial activity. Photo by Michael Lüth, with permission.

Figure 20. Atrichum undulatum is a moss that is very
effective against a wide range of bacteria. Photo by Michael
Lüth.

Figure 23. Timmiella sp., a genus with high antibacterial
activity. Photo by Ken-ichi Ueda through Creative Commons.

Figure 21. Enterobacter aerogenes, a bacterium that seems
to be resistant to extracts of 18 moss species that negatively affect
other bacteria. Photo by Alexa Rakusin Muna, through Creative
Commons.

Gupta and Singh (1971) found high occurrence of
antibacterial activity in extracts of Barbula species (Figure
22), reaching as high as 36.2%, whereas it was only half
that in Timmiella species (Figure 23) (18.8%). In 1982,
Asakawa et al. (1982) isolated three prenyl bibenzyls from
Radula spp. (Figure 24) and demonstrated that these

Figure 24. Radula complanata, a species with bibenzyls that
could inhibit growth of Staphylococcus aureus. Photo by Michael
Lüth, with permission.
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Figure 28. Reboulia hemisphaerica, member of a genus
with reported antimicrobial activity. Photo by Malcolm Storey
<www.discoverlife.org>, with online permission.

Figure 25. Staphylococcus aureus, a bacterium that is not
inhibited by the thallose liverwort Riccia fluitans. Photo by
NIAID, through Creative Commons.

Figure 29. Porella platyphylla, member of a genus with
reported antimicrobial activity. Photo by Tim Waters through
Creative Commons.

Figure 26. Magnaporthe grisea, a plant pest that is inhibited
by several liverworts. Photo by IRRI Photos, through Creative
Commons.

Figure 27. Pallavicinia lyellii, member of a genus with
reported antimicrobial activity. Photo by Jan-Peter Frahm, with
permission.

Another three species of mosses [Anomodon rostratus
(Figure 30), Plagiomnium cuspidatum (Figure 31),
Orthotrichum rupestre (Figure 32)] produce substances
that inhibit bacteria and fungi, but these inhibitors seem to
be unstable products that vary considerably among species
and possibly also among seasons (McCleary et al. 1960).
Indeed, it would appear that some of these antibiotic
compounds are the very ones that bryophytes produce in
response to stress. However useful they may be, it seems
that these discoveries have not yet found their way into
medical practice.

Figure 30. Anomodon rostratus, a species that inhibits
bacteria and fungi. Photo by Dale A. Zimmerman Herbarium,
Western New Mexico University, with permission.
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On the other hand, some researchers claim that
antibiotic properties of some mosses, including Sphagnum
(Figure 13, Figure 14), may actually be the work of
associated microorganisms.
In some cases, e.g.
Sphagnum, it may be Penicillium sp. (Figure 34) effecting
this antibiotic ability (Lewington 1990). Or is it the closely
associated Cyanobacteria, such as Nostoc (Figure 35)
(Spjut et al. 1988; Solheim & Zielke 2002)?

Figure 31. Plagiomnium cuspidatum, a species that inhibits
bacteria and fungi. Photo by Štĕpán Koval, with permission.

Figure 34. Penicillium expansum on pear, in a genus that
can grow on Sphagnum and may contribute to its antibiotic
effects. Photo by H. J. Larsen, through Creative Commons.

Figure 32. Orthotrichum rupestre, a species that inhibits
bacteria and fungi. Photo by Michael Lüth, with permission.

Scientists have found innumerable kinds of biological
activity in compounds from bryophytes. Even in a single
species, one might find multiple kinds of activity. For
example, the liverworts Plagiochasma japonica and
Marchantia emarginata subsp. tosana (Figure 33) exhibit
antitumor activity, antifungal and antimicrobial activity,
inhibition of superoxide release, inhibition of thrombin
activity, and muscle relaxation (Lahlou et al. 2000). As is
often the case with herbal medicine, the effect of the total
extract is better than that of the isolated compounds,
perhaps due to a synergistic effect (Frahm 2004).

Figure 33. Marchantia emarginata subsp. tosana, a
subspecies with a wide range of medicinal properties. Photo by
Taiwan Mosses, through Creative Commons.

Figure 35. Nostoc pruniforme, in a genus with close
associations with Sphagnum and other bryophytes and could
contribute to antibiotic properties. Photo by Lairich Rig, through
Creative Commons.

Painter (2003) notes that Sphagnum (Figure 13, Figure
14) can be 3-4 times as absorbent as cotton equivalents.
But its call to fame seems to be its ability to react
chemically with all sorts of proteins. Sphagnum species
have the potential to immobilize whole bacterial cells,
enzymes, exotoxins, and lysins that are secreted by most of
the invasive pathogens. Once these are immobilized, they
are inactivated by a Maillard reaction.
The Maillard reaction makes this story complex. It is
known to suppress the virulence gene expression operon in
the bacterium Listeria monocytogenes (Figure 36) (SheikhZeinoddin et al. 2000), so that is a good thing. On the
other hand, a variety of foods form potential cancer-causing
acrylamides, especially fried foods (Stadler et al. 2002).
Such acrylamides can be released by thermally treating
certain amino acids such as asparagine, especially in
combination with reducing sugars through the Maillard
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reaction. The early Maillard reaction products are Nglycosides. Painter (1998) found that the Maillard reaction
inhibits microbial growth in animal products preserved in
bogs by sequestering ammonia, amino acids, and peptides,
whereas the polymeric end-products (melanoidins) inhibit
their growth by cross-linking the polypeptide chains and
sequestering essential multivalent metal cations. In short,
the Maillard reaction appears to be an important component
of the Sphagnum (Figure 13, Figure 14) antibiotic activity.
Furthermore, its preservative ability correlates with α-ketocarboxylate groups in a glycuronoglycan (sphagnan) that
comprises ∼60% of the holocellulose in the Sphagnum
hyaline cell walls.
Figure 38.
Spodoptera littoralis, a species that is
discouraged from eating the liverwort Riccardia polyclada by its
chemical compounds. Photo from Forestry Images, through
Creative Commons.

Figure 36. Listeria monocytogenes, a bacteria species that is
inhibited by extracts of the leafy liverwort Porella cordaeana.
Photo from CDC, through public domain.

Harris (2009) considered phylogenetic, elevational,
and latitudinal relationships of the production of flavonoids
in medicinal mosses. He was unable to show any
significant correlation between phylogenetic independent
contrasts of total phenolic content, number of flavonoids,
or percent luteolin derivatives. He furthermore found no
correlation with elevation or latitude. He could not rule out
the possible correlation with fine-scale ecological features,
and he considered flavonoid variation to reflect recent
evolution.
Labbé et al. (2007) tested the thallose liverwort
Riccardia polyclada for potential pesticidal properties.
They identified four compounds that contributed to
lethality in the brine shrimp (Artemia salina; Figure 37).
Two of the compounds had moderate activity as an
antifeedant for the African cotton leafworm (Spodoptera
littoralis; Figure 38). They also inhibited culture growth of
the fungal plant pathogen Cladosporium herbarum (Figure
39).

Figure 37. Artemia salina, a species that is killed by extracts
from the liverwort Riccardia polyclada.
Photo by Hans
Hillewaert, through Creative Commons.

Figure 39. Cladosporium spp., fungal pathogens that are
inhibited by extracts from the liverwort Riccardia polyclada.
Photo from Mold Treatment Centers of America, through Creative
Commons.

Antimicrobial Activity
Our knowledge of antimicrobial activity of bryophytes
is mostly based on Sphagnum (Figure 13, Figure 14).
However other bryophytes are now known to have
antibiotic properties. Some of these may just be folklore as
they have not been tested experimentally. For example,
Cheng et al. (2008) reported the folk use of Polytrichum to
treat pneumonia.
And we have already seen that
Polytrichum commune (Figure 19) is used in a tea for
treating colds (Gulabani 1974; Beike et al. 2010).
Nevertheless, antibiotic properties have been
demonstrated in the laboratory. Moss activity against
Gram-positive and Gram-negative bacteria have been
demonstrated (Basile et al. 1999; Merkuria et al. 2005; Zhu
et al. 2006). Asakawa (2007a, b) has demonstrated many
effects of liverworts.
Kumar et al. (2007), in their review of classical
ethnobotanical Indian uses, reported the antibacterial value
of the mosses Anomodon rostratus (Figure 30), Atrichum
angustatum (Figure 40), A. undulatum (Figure 41), and
Hyophila involuta (Figure 42) and the thallose liverworts
Conocephalum conicum (Figure 10) and Dumortiera
hirsuta (Figure 15). These bryophytes reportedly produce
antibiotics. The leafy liverwort Radula complanata
(Figure 24) similarly has antimicrobial properties. To these
we can add the antiseptic properties of Frullania tamarisci
(Figure 43) (Asakawa 2007b; Chandra et al. 2017) and
antimicrobial activity of Pallavicinia sp. (Figure 27)
(Azuelo et al. 2011; Chandra et al. 2017).
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Figure 40.
Atrichum angustatum, a species with
antibacterial properties. Photo by Janice Glime.

Figure 41.
Atrichum undulatum, a species with
antibacterial properties.
Photo by Brian Eversham, with
permission.

Figure 42. Hyophila involuta, a species with antibacterial
properties. Photo by Michael Lüth, with permission.

Figure 43. Frullania tamarisci, an epiphytic species with
antiseptic properties, having both allergenic and medicinal
properties. Photo by Michael Lüth, with permission.

Recent tests on the floating thallose liverwort Riccia
fluitans (Figure 44) from Florida indicated no ability to
inhibit growth of the tested bacteria [Pseudomonas
aeruginosa (Figure 45), Staphylococcus aureus (Figure
25)] or yeast (Candida albicans; Figure 46) (Pates &
Madsen 1955). Vashistha et al. (2007) determined the
antimicrobial activity of three other thallose liverworts.
They found that water soluble extracts from
Conocephalum conicum (Figure 10), Marchantia
polymorpha
(Figure
47),
and
Plagiochasma
appendiculatum (Figure 48) had no effect on any of the
pathogens tested [Gram-negative bacteria Escherichia coli
(Figure 17) and Salmonella typhi (a variant of S. enterica;
Figure 49)] and fungi Aspergillus niger (Figure 50) and
yeast Candida albicans (Figure 46). However, acetonesoluble extracts of all three bryophyte species were
inhibitory against the pathogens. They were more effective
against the growth of S. typhi than against E. coli.
Plagiochasma appendiculatum had a strong inhibitory
effect against A. niger and Conocephalum conicum was
strongly inhibitory to Candida albicans.

Figure 44. Riccia fluitans, a species that was unable to
inhibit the growth of several tested bacteria. Photo by Štĕpán
Koval, with permission.
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Figure 45. Pseudomonas aeruginosa, a species that is not
inhibited by Riccia fluitans. Photo by Janice Haney Carr,
through Creative Commons.

Figure 46. Candida albicans, a yeast species that is inhibited
by extracts of the liverworts Conocephalum conicum,
Marchantia polymorpha, and Plagiochasma appendiculatum,
but not Riccia fluitans. Photo from Public Health Image Library,
through public domain.
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Figure 48. Plagiochasma appendiculatum, a species that is
effective against some pathogens. Photo by Ying Jia-dong,
through Creative Commons.

Figure 49. Salmonella enterica invading human cells.
Photo by NIAID, through public domain.

Figure 50. Aspergillus niger, a fungal species that is
inhibited by extracts of the liverworts Conocephalum conicum,
Marchantia polymorpha, and Plagiochasma appendiculatum.
Photo from Public Health Image Library, through public domain.

Figure 47. Marchantia polymorpha subsp. ruderalis. This
species had no effect on the fungi or Gram negative bacteria
tested by Vashistha et al. Photo by Malcolm Storey, through
Creative Commons

Bukvicki et al. (2012), using solid-phase
microextraction-gas chromatography mass spectrometry,
explored the volatile components of the leafy liverwort
Porella cordaeana (Figure 51). Using methanol, ethanol,
and ethyl acetate to extract terpenoids, they were able to
identify sesquiterpene hydrocarbons and monoterpene
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hydrocarbons. These same hydrocarbons were active
against the eleven food microorganisms tested, but at
different concentrations among the microorganisms. The
fungi among these will be discussed blow. Affected
bacterial strains were Salmonella enteritidis (food
poisoning that causes diarrhea, fever, and abdominal
cramps; Figure 52), Escherichia coli (commonly found in
lower intestine of warm-blooded organisms with some
strains causing food poisoning; Figure 17), and Listeria
monocytogenes (very virulent food pathogen that causes the
infection listeriosis; Figure 36). Methanol extracts showed
the best activity.
Figure 53. SEM of Bacillus subtilis, a species that is
inhibited by extracts of several bryophyte species. Photo by
Davehwng, through Creative Commons.

Figure 51. Porella cordaeana, a species that is able to
inhibit a variety of yeasts and bacteria. Photo by J. C. Schou, with
permission.
Figure 54. Micrococcus luteus, a bacteria species that is
inhibited by extracts of several bryophyte species. Photo by
Janice Carr, through public domain.

Basile et al. (1999) isolated seven pure flavonoids
from five species of mosses. Some of these exhibited
strong antibacterial effects against the bacteria
Enterobacter cloaceae (Figure 55), E. aerogenes (Figure
56), and Pseudomonas aeruginosa (Figure 45). They were
mainly active against Gram-negative bacteria that caused
severe opportunistic infections and were at the same time
resistant to commonly used antibacterial therapy. This
means that the bryophyte products could become important
tools in treating some bacterial infections.

Figure 52. Salmonella enteritidis, a bacteria species that is
inhibited by extracts of Porella cordaeana. Photo through OGL
(public domain).

It appears that differences in bryophyte extract activity
among various pathogens may be common. Extracts of the
liverworts Marchantia polymorpha (Figure 47), Porella
platyphylla (Figure 29), and the moss Dicranum
scoparium (Figure 16) showed antimicrobial effects on the
Gram-positive bacteria Bacillus subtilis (Figure 53),
Staphylococcus aureus (Figure 25), and Micrococcus luteus
(Figure 54) (Pavletic & Stilinovic 1963; Frahm 2004).
These same bryophytes exhibited no activity against Gramnegative Escherichia coli (Figure 17).

Figure 55. Enterobacter cloaceae, a species that is active
against Gram-negative bacteria. Photo by Nathan Reading,
through Creative Commons.
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Figure 56. Enterobacter aerogenes, a species that is active
against Gram-negative bacteria. Photo by Riraq25, through
Creative Commons.

Ariyo et al. (2011) compared the efficacy of extracts
from the Nigerian thallose liverwort Riccia nigerica as
antimicrobial agents. These extracts were tested against the
bacteria Bacillus subtilis (Figure 53), Pseudomonas
aeruginosa (Figure 45), Shigella dysenteriae (Figure 57),
and Staphylococcus aureus (Figure 25) and fungi Rhizopus
spp. (Figure 58), Aspergillus flavus (Figure 59), A. niger
(Figure 50), Penicillium spp. (Figure 34), and and
demonstrated strong significant antibacterial and antifungal
activity.

Figure 59. Aspergillus flavus, a fungal species that is
inhibited by extracts of Riccia nigerica. Photo by Medmyco,
through Creative Commons.

The leafy liverwort Ptilidium pulcherrimum (Figure
60) exhibits antimocrobial activity against both Gram +
bacteria and Gram negative bacteria, but the effect is
greater on the Gram positive bacteria (Veljić et al. 2010).

Figure 57. Shigella dysenteriae, a bacterial species that is
inhibited by extracts of Riccia nigerica. Photo by Public Health
Image Library, through public domain.
Figure 60. Ptilidium pulcherrimum, a species that is
effective against both Gram positive and Gram negative bacteria.
Photo by Hermann Schachner, through Creative Commons

Antifungal Activity

Figure 58. Rhizopus on yam, a fungal species that is
inhibited by extracts of Riccia nigerica. Photo by Charles
Averre, through Creative Commons.

Although mosses are known to harbor fungi and will
quickly become infected if kept moist in a plastic bag,
some fungi are inhibited by many species of bryophytes,
including many that cause skin infections. Jennings (1926)
reported moss immunity to molds as early as 1926, but the
possibility of using them as a source of antifungal activity
seems to have been largely overlooked. Among these, the
cosmopolitan moss Hypnum cupressiforme (Figure 61)
has remarkable antibacterial and antifungal effects. Ven
Hoof et al. (1981) demonstrated strong antibacterial and
antifungal effects by extracts of Hypnum cupressiforme.
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Figure 61. Hypnum cupressiforme, a species that is
effective against fungi that cause skin infections. Photo by
Michael Lüth.

Kumar et al. (2007) report antifungal properties for the
widespread leafy liverwort Porella platyphylla (Figure 29).
Ando and Matsuo (1984) demonstrated antifungal effects
of bryophytes on human pathogenic fungi, but they warned
that while the bryophyte extracts have fungicidal and
antifeedant effects, they also may cause allergic reactions
and dermatitis for some humans.
Bukvicki et al. (2012), using solid-phase
microextraction-gas chromatography mass spectrometry,
explored the volatile components of the related liverwort
Porella cordaeana (Figure 51). Using methanol, ethanol,
and ethyl acetate to extract terpenoids, they were able to
identify sesquiterpene hydrocarbons and monoterpene
hydrocarbons. These same hydrocarbons were active
against the eleven food microorganisms tested, but at
different concentrations among the microorganisms. These
included the yeasts Saccharomyces cerevisiae (yeast used
in wine making, baking, and brewing, but antibodies
against S. cerevisiae are found in 60-70% of patients with
Crohn's disease; Figure 62), Zygosaccharomyces bailii
(species causing significant spoilage in the food industry;
Figure 63), Aureobasidium pullulans (an inhabitant
of humidifiers or air conditioners that can lead to
hypersensitivity pneumonitis;
Figure
64),
Pichia
membranifaciens (species causing grey mold of fruits;
Figure 65) (2 strains), Pichia anomala (used in
winemaking) (2 strains), and Yarrowia lipolytica (used in
industrial microbiology for production of specialty lipids).
Methanol extracts showed the best activity.

Figure 63. Zygosaccharomyces bailii, a yeast species that is
inhibited by extracts of Porella cordaeana. Photo by DTDT,
through Creative Commons.

Figure 64. Aureobasidium pullulans, a yeast species that is
inhibited by extracts of the leafy liverwort Porella cordaeana.
Photo by Tom Volk, through Creative Commons.

Figure 65. Pichia membranaefaciens, a yeast species that is
inhibited by extracts of Porella cordaeana. Photo by Luciana
Francisco Fleuri & Hélia Harumi Sato, through Creative
Commons.

Figure 62. Saccharomyces cerevisiae SEM, a yeast species
that is inhibited by extracts of the leafy liverwort Porella
cordaeana. Photo by Mogana Das Murtey and Patchamuthu
Ramasamy, through Creative Commons.

The leafy liverwort Ptilidium pulcherrimum (Figure
60) is not only effective against bacteria, but also against
fungi (Veljić et al. 2010). Its best antifungal activity was
against Trichoderma viride (Figure 66), compared to the
activity of the synthetic bifonazol.
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Figure 66. Trichoderma viride conidiophores, a fungal
species that is inhibited by Atrichum undulatum, Physcomitrella
patens, and Marchantia polymorpha. Photo by Ninjatacoshell,
through Creative Commons.

The absence of fungal diseases in liverworts led Pryce
(1972) to suggest that lunularic acid, a hormone that
affects aging in liverworts but not in mosses, might be
responsible for liverwort antifungal activity. Banerjee and
Sen (1979; Bannerjee 1974) found that the degree of
antibiotic activity in a given species may depend on the age
of the gametophyte; Matsuo et al. (1982a, 1982b, 1983)
supported this conclusion by demonstrating that antifungal
activity against Botrytis cinerea (Figure 67), Pythium
debaryanum (Figure 68), and Rhizoctonia solani (Figure
69) by the liverwort Herbertus aduncus (Figure 70) was
age-dependent. They subsequently isolated three aging
substances from it:
(-)-alpha-herbertenol; (-)-Betaherbertenol, and (-)-alpha-formylherbertenol.
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Figure 68. Pythium sp. The liverwort Herbertus aduncus
can exercise antifungal activity against this fungus, but activity is
age-dependent. Photo by Josef Reischig, through Creative
Commons.

Figure 69. Rhizoctonia solani infecting leaves.
The
liverwort Herbertus aduncus can exercise antifungal activity
against this fungus, but activity is age-dependent. Photo by
Howard F. Schwartz, through Creative Commons.

Figure 70. Herbertus aduncus, a leafy liverwort that can
exercise antifungal activity against several fungi, but activity is
age-dependent. Photo by Martin Hutten, with permission.

Figure 67. Botrytis cinerea on grapes. The liverwort
Herbertus aduncus can exercise antifungal activity against this
fungus, but activity is age-dependent. Photo by Alexandre
Dulaunoy, through Creative Commons.

Vashistha et al. (2007) determined the antimicrobial
activity for the thallose liverworts Plagiochasma
appendiculatum (Figure 48), Marchantia polymorpha
(Figure 47), and Conocephalum conicum (Figure 10).
Acetone-soluble extracts of all three bryophyte species
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were inhibitory against the fungal pathogens tested.
Plagiochasma appendiculatum had a strong inhibitory
effect against Aspergillus. niger and C. conicum was
strongly inhibitory to Candida albicans. When Niu et al.
(2006) tested Marchantia polymorpha (Figure 47) for
antifungal activities against the yeast Candida albicans
(Figure 46), they found plagiochin E, 13,13'-Oisoproylidenericcardin D, and neomarchantin A were active
against the yeast. The other identified compounds had only
weak effects.
Sabovljević et al. (2011) used DMSO extracts of both
cultured and wild grown mosses Atrichum undulatum
(Figure 20) and Physcomitrella patens (Figure 71-Figure
72) and thallose liverwort Marchantia polymorpha ssp.
ruderalis (Figure 47) to test for antifungal activity. Using
Aspergillus versicolor (Figure 73), Aspergillus fumigatus
(Figure 74), Penicillium funiculosum (see Figure 34),
Penicillium ochrochloron, and Trichoderma viride (Figure
66), these researchers demonstrated antifungal activity by
all three bryophytes against all five fungal species. Most of
the bryophytes grown in culture had greater antibiotic
activity than the wild-grown ones.

Figure 73. Aspergillus versicolor, a fungal species that is
inhibited by Atrichum undulatum, Physcomitrella patens, and
Marchantia polymorpha.
Photo by James Scott, through
Creative Commons.

Figure 71. Physcomitrella patens growing on agar plates.
Photo by Sabisteb, through Creative Commons.
Figure 74. Aspergillus fumigatus, a fungal species that is
inhibited by Atrichum undulatum, Physcomitrella patens, and
Marchantia polymorpha. Photo through Creative Commons.

Figure 72. Physcomitrella patens, a source of human
proteins and blood-clotting factor IX. Photo by Michael Lüth.

Alcoholic extracts of all twenty bryophytes tested at
Bonn University had antifungal activity on infected crops
(Frahm 2004), as demonstrated in a Petri dish (Figure 75).
Frahm reports curing a fungal infection of the skin with a
bryophyte extract. The success was reported in a TV
magazine and a published book, causing a number of
people to use the extract for fungal infections, mostly with
favorable results.
However, Frahm warns that the
biologically active substances are terpenoids, and these
may cause allergic effects to some people (Ando & Matsuo
1984). One reputedly can cure athlete's foot by walking
through a peat bog, presumably because of these same
terpenoids (Frahm 2004).
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Figure 75. Bryophytes are known to inhibit growth of some
kinds of bacteria and fungi. Left: Microbes grow uninhibited
around a disk with only extraction fluid. Right: A zone of
inhibition occurs around the disk with bryophyte extract. Photo
by Jan-Peter Frahm.

One extract has actually been patented to cure fungal
infections of horses (Frahm 2004). An industrious horse
owner was inspired by what he read about the Bonn
experiments and made a paste of Ceratodon purpureus
(Figure 76) and Bryum argenteum (Figure 77). The
fungus disappeared from the horse in 24 hours! This same
extract is also sold as a human foot cream to refresh and
fight odor. Unfortunately, the use for curing fungal
infections cannot be mentioned in advertising because then
it would require the extensive testing necessary to meet
medical approval, which might be difficult because it can
cause allergies and dermatitis in some people. It also
works as an antifeedant against slugs. Unfortunately, to
date it must be extracted from field-collected material,
creating conservation concerns.

2-2-17

Figure 77. Bryum argenteum, a species that was used in a
paste with Ceratodon purpureus and killed a fungal infection on
a horse. Photo by Martin Hutten, with permission.

Figure 78.
Chaetomium globosum.
The fungus
Chaetomium fusiforme occurs on Scapania verrucosa and
produces both antifungal and antitumor compounds. Photo by
Ulitca, through Creative Commons.

Antiviral Activity

Figure 76. Ceratodon purpureus, a species was used with
Bryum argenteum and killed a fungal infection on a horse. Photo
by Janice Glime.

It appears that some bryophytes may contribute to
antifungal compounds by hosting a fungus that
manufactures both antifungal and antitumor compounds
(Guo et al. 2008). The leafy liverwort Scapania verrucosa
hosts the fungus Chaetomium fusiforme (Figure 78). Not
only does the latter produce both antifungal and antitumor
compounds, but the liverwort itself likewise produces them.
However, the fungus compounds provide superior
properties and the liverwort might contribute to the
medicinal field through this fungal endophyte (organisms
growing within cells of plant, ranging from symbiotic to
parasitic).

Even viruses may some day be cured by extracts of
mosses, but we cannot simply identify them as "moss" as
many of our ecologist friends have been wanton to do in
reporting the ground cover. The Maoris of New Zealand
have used bryophytes to treat venereal disease by packing
wet plants on the infected organs (Frahm 2004).
Nevertheless, van Hoof and coworkers (1981) found no
effect of 20 species of moss extracts on the herpes virus,
but earlier Klöcking et al. (1976) found that at least some
peat humic acids possess antiviral activity against herpes
simplex virus types 1 and 2, interfering primarily with the
adsorption of viruses to host cells.
Sphagnum (Figure 13, Figure 14) produces several
antivirally active humic acids, and Camptothecium (Figure
79) extracts can inhibit growth of the poliovirus (Witthauer
et al. 1976; van Hoof et al. 1981). Nevertheless, actual
usage of bryophytic extracts has not developed outside of
Asia.
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Kumar et al. (2007) found that Indians have used
Polytrichum juniperinum (Figure 80) to treat cancer. The
anti-tumor use of bryophytes in India included
Chiloscyphus polyanthos (Figure 81), Diplophyllum
albicans
(Figure 82), D. taxifolium (Figure 85),
Marchantia palmata, and M. polymorpha (Figure 47).
Frullania tamarisci (Figure 43) is used as an antileukemic
agent. To this list, others added Riccardia sp. (Figure 84)
(Azuelo et al. 2011; Alam 2012; Chandra et al. 2017) and
Plagiochila sp. (Figure 11) (Asakawa 2007; Alam 2012;
Chandra et al. 2017).

Figure 79. Camptothecium lutescens, in a genus that can
inhibit growth of the poliovirus. Photo by David T. Holyoak,
with permission.

Cancer and Anti-tumor Properties
In the same year as the Madsen and Pates (1952) report
of antibiotics in bryophytes, Belkin et al. (1952-53)
reported anticancer activity against Sarcoma 37 in mice,
using extracts of Polytrichum juniperinum (Figure 80).
But application of the antitumor activity fared no better and
was apparently not rediscovered in bryophytes until the
next century. Finally, Anterola et al. (2009) considered the
anticancer drug precursors in mosses to be so important
that they titled their presentation on them "Turning
precursors into gold: Production of anticancer drug
precursors in moss."

Figure 80. Polytrichum juniperinum with antheridial splash
cups, a species that produces anticancer compounds. Photo by
Paul Slichter, with permission.

Fu et al. (2009) attempted to show anti-cancer
capabilities of the moss Polytrichum commune (Figure
19). To this end, they isolated two "unusual" flavones and
other compounds from this moss. However, when tested
against a small panel of cancer cell lines, they failed to find
any activity.

Figure 81. Chiloscyphus polyanthos, a species that may
cause allergic reactions.
Photo by Barry Stewart, with
permission.

Figure 82. Diplophyllum albicans, used as an anti-tumor
treatment in India and as an agent against epidermoid carcinoma.
Photo by Michael Lüth, with permission.

Asakawa (1981) has shown that several compounds
from leafy liverworts exhibit antileukemic activity. From
the thallose species, Marchantin A from Marchantia
palacea (Figure 83), M. polymorpha (Figure 47), and M.
emarginata subsp. tosana (Figure 33), riccardin from
Riccardia multifida (Figure 84), and perrottetin E from
Radula perrottetii all show cytotoxicity against the
leukemic KB cells (Asakawa et al. 1982).
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Hughes and Anterola (2010) attempted to transplant
genes for producing Taxol (a potent anticancer agent) into
the moss Physcomitrella patens (Figure 71, Figure 72).
They found evidence of small amounts of the anticancer
precursors in the moss. If the moss can be taught
(genetically) to produce Taxol, it could become a
laboratory means to manufacture this important anti-cancer
drug without destroying the diminishing number of Taxus
(Figure 86) shrubs that produce it naturally. Bryophytes
are ideal organisms for such gene transplants because of
their dominant state with a single set of chromosomes and
the relative ease with which genes can be put into them.

Figure 83. Marchantia paleacea, a thallose liverwort known
for its antileukemic activity. Photo by Jan-Peter Frahm, with
permission.

Figure 86. Taxus baccata, member of the genus that
produces the anticancer agent Taxol. Photo through Creative
Commons.

In 1976, Adamek reported that peat preparations hold
some promise against some types of human cancer. In
1977, Ohta and coworkers (1977) reported that
diplophyllin, isolated from the liverworts Diplophyllum
albicans (Figure 82) and D. taxifolium (Figure 85), shows
significant activity (ED50 4-16 µg/ml) against human
epidermoid carcinoma (KB cell culture).

When Asakawa (1981, 1982) entered the arena, he
isolated the sesquiterpenoids costunolide and tulipinolide
from Conocephalum supradecompositum, Frullania
monocera, F. tamarisci (Figure 43), Marchantia
polymorpha (Figure 47), Wiesnerella denudata (Figure 87)
and Porella japonica (Figure 88). To this list, Matsuo and
coworkers (1980, 1981a, b, c, 1984) added Lepidozia vitrea
(Figure 89) and Plagiochila semidecurrens (Figure 90).
These substances, already known from higher plants, have
activity to combat carcinoma of the nasopharynx, at least in
cell culture.

Figure 85. Diplophyllum taxifolium, a species that produces
diplophyllin, a compound that is active against human epidermoid
carcinoma. Photo by Hermann Schachner, through Creative
Commons.

Figure 87. Wiesnerella denudata, a species that produces
sesquiterpenoids that are likely to have antibiotic properties.
Photo by Ying Jia-dong, through Creative Commons.

Figure 84. Riccardia multifida, a thallose liverwort known
for its antileukemic activity. Photo by Michael Lüth, with
permission.
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Figure 90. Plagiochila semidecurrens, a species that
produces compounds that combat carcinoma of the nasopharynx.
Photo by Martin Hutten, with permission.

Figure 88. Porella japonica, a species that produces
compounds that combat carcinoma of the nasopharynx. Photo
from Taiwan mosses color illustrations, through Creative
Commons.

Figure 89. Lepidozia vitrea, a species that produces
compounds that combat carcinoma of the nasopharynx. Photo by
Lin Shanxiong, through Creative Commons.

When the National Cancer Institute became interested,
Spjut and his coworkers (1986) tested 184 species of
mosses and 23 species of liverworts for antitumor activity.
Of these, 43 species contained active substances, while
those of 75 species were toxic to tested mice. The most
activity was found in Brachytheciaceae (Figure 91),
Dicranaceae (Figure 16), Grimmiaceae (Figure 92),
Hypnaceae (Figure 61), Mniaceae (Figure 18, Figure 31),
Neckeraceae (Figure 2), Polytrichaceae (Figure 19,
Figure 80), and Thuidiaceae (Figure 93). However, in
1988, doubt was cast on the role of the moss when this
team reported that the antitumor activity of the moss
Claopodium crispifolium (Figure 94) was greatest in
samples contaminated with the Cyanobacterium Nostoc cf.
microscopicum (Figure 95), suggesting that Nostoc could
be the direct source of the activity or a necessary partner
for interaction between the species (Spjut et al. 1988).
Interaction could result from the transfer of a precursor
from the Nostoc to the moss, which could then transform it
into an active substance. Alternatively, the moss might
produce the substance as an allelopathic response to the
Nostoc. In any event, this raises important and intriguing
questions, both medically and ecologically.

Figure 91. Brachythecium salebrosum (Brachytheciaceae).
Some members of this family exhibit high antitumor activity.
Photo by Hermann Schachner, through Creative Commons.
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Figure 92. Grimmia nutans (Grimmiaceae).
Some
members of this family exhibit high antitumor activity. Photo by
Michael Lüth, with permission.
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Figure 95. Nostoc sp., a moss contaminant that can increase
anti-tumor activity.
Photo from Retina, through Creative
Commons.

For some reason, much of the biochemical work has
concentrated on the liverworts. Similar studies on activities
of moss compounds are sparse and there may be good
reason to presume a greater medical treasure chest among
the liverworts. Since these compounds generally benefit
the bryophytes by discouraging their would-be herbivores,
it is the tiny, slow-growing liverworts that stand to benefit
most.
Where other, larger plants have spent their
evolutionary history developing a diversity of structure, it
would seem that small size has afforded these plants only
the benefits of diversity of biochemistry as a means of
combating the hungry herbivores.
Burgess et al. (2000) found that the leafy liverwort
Bazzania novae-zelandiae (Figure 96) produces a
sesquiterpene caffeate that has selective activity against
certain human tumor cells. The active compound has been
identified as the new compound naviculyl caffeate.
Figure 93. Thuidium tamariscinum (Thuidiaceae). Some
members of this family exhibit high antitumor activity. Photo by
Malcolm Storey (DiscoverLife.com), with online permission.

Figure 96. Bazzania novae-zealandiae, a species that is
active against human tumor cells. Photo by Shirley Kerr, with
permission.
Figure 94. Claopodium crispifolium, a moss that provides
habitat for Nostoc, which in turn has anti-tumor properties. Photo
from Botany Website, UBC, with permission.

Even breast cancer sufferers might benefit from
bryophytes. Huang et al. (2010) found that marchantin A
produced by Marchantia emarginata subsp. tosana
(Figure 33) induced apoptosis in MCF-7 breast cancer
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cells. This compound demonstrates strong antioxidant
activity, scavenging free radicals.
The leafy liverwort Scapania verrucosa and its
endophytic fungal inhabitant Chaetomium fusiforme (see
Figure 78) produce several compounds that act as
antitumor agents (Guo et al. 2008).
The thallose liverwort Dumortiera hirsuta (Figure 15)
produces riccardin D, a macrocyclic bisbibenzyl
compound that induces apoptosis of human leukemia cells
(Xue et al. 2012). Xue and coworkers verified anticancer
activity by riccardin D against human non-small cell lung
cancer. In mice it produced a 44.5% inhibition of cancer
growth with no apparent toxicity.

complex moss system, compared to bacteria and fungi,
permits a much wider array of expression than is possible
in those systems. Thus, mosses are extremely useful as
production systems for targeted substances that can be
produced through gene manipulation.

Pharmaceutical Production
Welcome to Greenovation! Moss for a healthy future.
So began the website <http://www.greenovation.com/> of
an upstart company that is growing the tiny Physcomitrella
patens (Figure 71, Figure 72) for medicinal purposes. Yes,
bryophytes have indeed finally penetrated the forefront of
modern medicine!
Physcomitrella patens (Figure 71, Figure 72) is able to
accept transferred human genes and express them to
produce human antibodies in a liquid culture, making the
antibodies easy to harvest (ETH Zurich 2009). So far, this
is not possible when the genes are transplanted into "higher'
organisms. One advantage of Physcomitrella patens is its
ability to grow in a "bioreactor" (Figure 97; Decker &
Reski 2004), a fermenter in which only water and minerals
are needed to nourish the moss, of course in the presence of
light and CO2 (Greenovation). These tiny plants are
actually superior (and cheaper) production systems for
many complex recombinant pharmaceuticals (Bauer et al.
2005; Decker & Reski 2007, 2012; Gitzinger et al. 2009).
Contrary to many mammalian systems that have been used
to produce pharmaceuticals but that cause serious immune
responses, those produced by Physcomitrella patens are
non-immunogenic, a huge advantage for the patient, and
making them superior to currently used mammalian cell
lines for producing antibodies.
Among its many assets, Physcomitrella patens (Figure
71, Figure 72) is able to produce human proteins (Hohe et
al. 2002; Decker et al. 2003) and is the only plant being
used to produce the blood-clotting factor IX for
pharmaceutical use. This discovery, patented by Prof.
Reski of the Institute of Biotechnology of Plants at the
University of Freiburg in Germany, led to the founding of
the Greenovation Company in 1999. By 2002, the
company was already employing 30 people to produce this
valuable blood factor (Frahm, Bryonet discussion 2002).
Bryophytes offer the researchers, and the company, a
number of advantages over "higher" plants. They can be
grown without antibiotics, hence avoiding the danger of
contamination of the final product. The moss is quite small
and thus is cultured only in the lab with little danger of the
transgenic plants escaping into the environment. But the
real advantage comes from the dominant gametophytic
generation of mosses as opposed to the dominant
sporophyte of the tracheophytes. As a result, mosses are
the only plants known to have a high frequency of
homologous recombination. The result – stable integration
of inserted genes into the genome. Furthermore, the highly

Figure 97. This type of bioreactor is used to grow
Physcomitrella patens for human proteins and human bloodclotting factor IX. Photo by Ralf Reski.

Unfortunately, most biologically active substances so
far obtained have not proved economical for use, at least in
part due to the slow-growing nature and difficulty of
culturing bryophytes. And, while their pharmaceutical use
seems promising, we lack any understanding of their
potential harmful side effects.
In the words of Ma et al. (2003), "Imagine a world in
which any protein, either naturally occurring or designed
by man, could be produced safely, inexpensively and in
almost unlimited quantities using only simple nutrients,
water and sunlight. This could one day become reality as
we learn to harness the power of plants for the production
of recombinant proteins on an agricultural scale. Molecular
farming in plants has already proven to be a successful way
of producing a range of technical proteins. The first plantderived recombinant pharmaceutical proteins are now
approaching commercial approval, and many more are
expected to follow."
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Medical Dangers
Caution is in order in exercising any medicinal use of
bryophytes, particularly liverworts, because of their
potential for causing allergic reactions (Mitchell et al.
1969, 1970; Benezra et al. 1985, Asakawa 2012). Often
the very compounds that have these medical potentials can
cause allergic reactions. For example, it is a sesquiterpene
lactone (Asakawa 1981) that gives the common epiphyte
Frullania (Figure 98-Figure 99) its ability to cause contact
dermatitis, especially to forest workers (Mitchell et al.
1969). Now there is a patch test with a sesquiterpene
lactone mix to determine sensitivity to Frullania (Quirce et
al. 1994).
Yet sesquiterpene lactones are well known for their
antimicrobial activity. In southern Europe, Frullania
tamarisci (Figure 43, Figure 98) imparts an allergic
reaction to olive pickers, yet is listed as one of the
medicinal species (J. Curnow, pers. comm.). D. H. Wagner
(pers. comm.) reports an allergy to Chiloscyphus
polyanthos (Figure 81), especially when he squeezes it to
remove excess water. By 1981, 24 liverwort species were
known to have potential allergenic sesquiterpene lactones
(Asakawa 1981). These compounds undoubtedly endow
the same advantage to bryophytes that they do to flowering
plants – discouraging consumption by hungry herbivores.

Figure 99. Frullania nisquallensis, a leafy liverwort
epiphyte that causes allergic reactions among forest workers.
Photo by Dale Vitt, with permission.

Figure 100. Thuja plicata, host plant for Frullania species.
Photo from <www.nwplants.com>, through Creative Commons.

Summary

Figure 98. Frullania tamarisci, showing underside of
branch with lobules by which the genus may be determined.
Photo by Michael Lüth, with permission.

Frullania tamarisci (Figure 43, Figure 98) grows on
trees and can cause skin irritations for loggers and even for
their wives who handle their clothes. Allergic reactions to
Frullania nisquallensis (Figure 99) occurred in patch tests
on seven forest workers who had contact dermatitis
(Mitchell et al. 1969). These forest workers exhibited the
dermatitis only when they were working on forest areas.
The problem was worse in wet weather and appeared
within 1-2 days of starting work. The condition persisted
for 2-4 weeks after leaving work in forested areas where
the liverwort grew. The condition is often known locally in
British Columbia, Canada, as cedar poisoning, but in fact it
is caused by the liverworts that commonly grow on the
cedars (Thuja; Figure 100).

Bryophytes, especially liverworts, often have
distinct odors, suggesting aromatic compounds such as
phenols. However, few bryophytes have been linked to
actual curative properties and identifiable associated
compounds.
One danger in using bryophytes is that the same
compounds that may have antibiotic properties may
also be toxic or allergenic, or be associated with such
compounds. Furthermore, peatland mosses may have
associated fungi that cause sporotrichosis.
Many antibiotics have been isolated from
bryophytes, but few have been developed for medical
use, despite their demonstrated effectiveness.
In
Germany, Ceratodon purpureus and Bryum
argenteum are used to cure fungal infections of horses.
Several medical uses seem promising, such as
antileukemic properties and anticancer agents.
The most promising uses of bryophytes in
medicine seem to lie in genetic engineering.
Bryophytes are being used already to produce human
blood-clotting proteins, while others are known to
reduce thrombin activity.
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